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A b s t r a c t 
Carcinoembryonic a n t i g e n (CEA) i s an o n c o f o e t a l 
a n t i g e n which has been demonstrated i n v a r i o u s tumour 
t i s s u e s and i n v e s t i g a t e d as a "tumour marker". C o n f l i c t i n g 
r e p o r t s have been made concerning the r e l a t i o n s h i p between 
the presence o f CEA i n breast carcinoma t i s s u e and the 
prog n o s i s o f the p a t i e n t . The present study was undertaken 
i n an a t t e m p t t o c l a r i f y t h i s r e l a t i o n s h i p . 
An immunohistochemical technique was employed i n the 
i n v e s t i g a t i o n o f 138 cases of primary b r e a s t carcinoma, 
presented a t Dryburn H o s p i t a l , Durham, and t r e a t e d by 
mastectomy. The subsequent progress o f these p a t i e n t s was 
then i n v e s t i g a t e d , s u r v i v a l estimated by the l i f e t a b l e 
method and comparisons made by the l o g rank t e s t . No 
r e l a t i o n s h i p was found between the presence o f CEA i n the 
tumour and p a t i e n t s u r v i v a l f o r up t o 8 years post surgery. 
S i m i l a r i n v e s t i g a t i o n s d e t e c t e d no r e l a t i o n s h i p between the 
presence o f CEA and the age, weight and menopausal s t a t u s 
o f the p a t i e n t or the presence o f synchronous lymph node 
metastases, or the h i s t o l o g i c a l grade or s i z e o f the 
tumour. 
I t t h e r e f o r e appears t h a t d e t e c t i o n o f CEA i n breast 
carcinomas i s o f no p r o g n o s t i c s i g n i f i c a n c e . 
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Chapter 1: INTRODUCTION 
O n c o f o e t a l a n t i g e n s 
H i r z f e l d , Halber and Rosenblat (1932) were the f i r s t 
t o demonstrate t h a t tumour t i s s u e s c o n t a i n e d a n t i g e n i c 
substances p r e v i o u s l y t h o u g h t t o be c o n f i n e d t o embryonic 
t i s s u e s . I n t e r e s t i n such o n c o f o e t a l a n t i g e n s was r e v i v e d 
by Abelev and h i s co-workers ( A b e l e v , Perova, Khramkova, 
Po s t n i k o v a and I r l i n , 1963) who d i s c o v e r e d a l p h a f e t o p r o t e i n 
i n c h e m i c a l l y induced murine hepatomas. Subsequently 
s e v e r a l o n c o f o e t a l a n t i g e n s have been d e s c r i b e d , and 
i n t e r e s t i n t h i s group o f p r o t e i n s has p e r s i s t e d due t o 
t h e i r p o t e n t i a l a p p l i c a t i o n i n the d e t e c t i o n , d i a g n o s i s , 
p r o p h y l a x i s and t h e r a p y o f cancer (see Alexander, 1972; 
Laurence and N e v i l l e , 1972; Costanza and Nathanson, 1974). 
Carcino embryonic a n t i g e n (CEA) i s an o n c o f o e t a l 
a n t i g e n which was f i r s t demonstrated i n human c o l o n i c 
tumours a f t e r a d i r e c t e d search (Gold and Freedman, 1965a). 
These workers prepared e x t r a c t s o f human c o l o n i c 
adenocarcinoma, r a i s e d a n t i s e r a t o these e x t r a c t s i n 
r a b b i t s and used an i m m u n o p r e c i p i t a t i o n t e c h n i q u e t o 
compare these w i t h e x t r a c t s o f normal c o l o n i c t i s s u e s taken 
from the same i n d i v i d u a l s . I n a l l cases CEA was c o n f i n e d t o 
the tumour t i s s u e s . Subsequently s m a l l e r amounts of CEA 
were found i n p r i m a r y carcinomas from o t h e r s i t e s a l o n g the 
g a s t r o i n t e s t i n a l t r a c t (oesophagus, stomach and pancreas) 
as w e l l as i n the l i v e r , but not i n normal a d u l t t i s s u e s or 
i n benign tumours o f the d i g e s t i v e t r a c t . CEA was n o t 
d e t e c t e d i n r e c t a l and c o l o n i c t i s s u e s which were a f f e c t e d 
by non n e o p l a s t i c diseases such as u l c e r a t i v e c o l i t i s and 
d i v e r t i c u l i t i s (Gold and Freedman, 1965b). I n the same 
s e r i e s o f experiments CEA was d e t e c t e d i n m e t a s t a t i c 
tumours o r i g i n a t i n g from a p r i m a r y tumour i n the 
g a s t r o i n t e s t i n a l t r a c t , even though the secondary tumours 
were a t s i t e s remote from the gut ( l u n g and l i v e r ) . 
C o nversely, CEA was not d e t e c t e d i n m e t a s t a t i c tumours o f 
the g u t which were d e r i v e d from p r i m a r y tumours o f the 
p r o s t a t e and o v a r y . I t was t h e r e f o r e concluded t h a t the 
presence o f t h i s a n t i g e n r e f l e c t e d t he s i t e o f the p r i m a r y 
tumour r a t h e r than the s i t e o f secondary g r o w t h . 
I n e x p eriments w i t h f o e t a l t i s s u e s Gold and Freedman 
(1965b) demonstrated t h a t CEA was p r e s e n t i n f o e t a l g u t , 
l i v e r and pancreas between 2 and 6 months g e s t a t i o n . They 
concluded t h a t CEA was a normal c e l l u l a r component o f 
c e r t a i n f o e t a l t i s s u e s whose p r o d u c t i o n was r e p r e s s e d 
d u r i n g the d i f f e r e n t i a t i o n o f the g a s t r o i n t e s t i n a l t r a c t . 
They proposed t h a t t he a n t i g e n reappeared d u r i n g 
oncogenesis by a process o f d e r e p r e s s i v e d e d i f f e r e n t i a t i o n 
(see Jacob and Monod, 1961). More r e c e n t s t u d i e s o f c e l l 
s u r f a c e a l t e r a t i o n s i n v i r a l l y induced tumours have 
suggested t h a t an e q u a l l y a p p r o p r i a t e mechanism may be the 
u n c o v e r i n g o f s u r f a c e a n t i g e n s a t " c r y p t i c " s i t e s which are 
n o t n o r m a l l y exposed i n a d u l t t i s s u e s (Hayry and D e f e n d i , 
1970; Burger, 1971). CEA was t h e r e f o r e regarded as h a v i n g 
p o t e n t i a l v a l u e i n the d i a g n o s i s o f c e r t a i n tumours o f the 
g a s t r o i n t e s t i n a l t r a c t . 
S ubsequently, CEA has been i s o l a t e d and shown t o be a 
w a t e r - s o l u b l e g l y c o p r o t e i n w i t h a m o l e c u l a r w e i g h t o f 
200,000. The c h e m i c a l p r o p e r t i e s o f CEA v a r i e d l i t t l e 
between d i f f e r e n t tumours (Krupey, Gold and Freedman, 1967, 
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1968) . The c e l l u l a r l o c a l i s a t i o n o f CEA was i n v e s t i g a t e d 
u s i n g immunofluorescence, ( G o l d , Gold and Freedman, 1968; 
von K l e i s t and B u r t i n , 1969) and e l e c t r o n microscope 
i m m u n o h i s t o c h e m i s t r y (G o l d , Krupey and Anson, 1970). I t was 
found t o be l o c a l i s e d t o t h e c e l l membranes and the 
s u p e r f i c i a l g l y c o c a l y x o f r e a c t i n g tumours. 
Gold (1967) found t h a t a n t i b o d i e s t o CEA c o u l d be 
found i n the sera o f 70% o f a l l p a t i e n t s p r e s e n t i n g w i t h 
p r i m a r y tumours o f the d i g e s t i v e t r a c t , w h i l s t i t was 
i n v a r i a b l y absent from p a t i e n t s i n whom d i s s e m i n a t i o n 
( d i s p e r s i o n of the d i s e a s e ) was known t o have o c c u r r e d . The 
a u t h o r proposed t h a t the anti-CEA a c t i v i t y was removed from 
the p a t i e n t ' s serum e i t h e r by being bound t o the tumour 
c e l l s , or by combining w i t h CEA r e l e a s e d i n t o the 
c i r c u l a t i o n by the tumour. However, C o l l a t z , von K l e i s t and 
B u r t i n (1971) found no evidence t h a t t h e r e were any 
s p e c i f i c anti-CEA a n t i b o d i e s i n p a t i e n t s ' sera and 
suggested t h a t t h i s p r o t e i n was not a u t o a n t i g e n i c , and t h a t 
t he a u t o a n t i b o d i e s demonstrated by Gold (1967) were 
d i r e c t e d a g a i n s t normal t i s s u e p r o t e i n s p r e s e n t i n 
p e r c h l o r i c a c i d e x t r a c t s o f c o l o n i c tumours. 
The n e x t development was the d i r e c t assay o f CEA i n 
the serum. Radioimmunoassay t e c h n i q u e s were m o d i f i e d t o 
p r o v i d e a s e n s i t i v e assay capable o f d e t e c t i n g 1-2 ng o f 
CEA per ml o f serum (Thompson, Krupey, Freedman and Gold, 
1969) . Using t h i s t e c h n i q u e CEA was d e t e c t e d i n t h e serum 
o f almost a l l p a t i e n t s w i t h adenocarcinoma o f the l a r g e 
i n t e s t i n e , but was not d e t e c t e d i n sera from p a t i e n t s w i t h 
m a l i g n a n c i e s a r i s i n g o u t s i d e t h e d i g e s t i v e system, from 
p a t i e n t s w i t h non-malignant diseases or from h e a l t h y 
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i n d i v i d u a l s . These f i n d i n g s s u p p o r t e d t he view t h a t CEA was 
a s y s t e m - s p e c i f i c o n c o f o e t a l a n t i g e n (Gold and Freedman, 
1965a, 1965b). 
M a r t i n and M a r t i n , ( 1 9 7 0 ) , u s i n g a m o d i f i c a t i o n o f the 
e x t r a c t i o n t e c h n i q u e d e s c r i b e d by Gold and Freedman, 
(1965a, 1965b), were a b l e t o demonstrate t h a t low 
c o n c e n t r a t i o n s o f CEA were p r e s e n t i n normal a d u l t c o l o n as 
w e l l as non m a l i g n a n t l y diseased c o l o n . These f i n d i n g s 
suggested t h a t the d i f f e r e n c e i n CEA l e v e l s between 
cancerous and non-cancerous t i s s u e s may be q u a n t a t a t i v e 
r a t h e r than q u a l i t a t i v e . S i m i l a r l y , Moore, Kupchik, Marcon 
and Zamchek ( 1 9 7 1 ) , u s i n g t he same t e c h n i q u e as Thompson 
e t a l . ( 1969), d e t e c t e d r a i s e d CEA t i t r e s i n p a t i e n t s w i t h 
tumours a r i s i n g o u t s i d e the g a s t r o i n t e s t i n a l t r a c t . CEA 
l e v e l s were a l s o e l e v a t e d i n p a t i e n t s w i t h c h r o n i c r e n a l 
f a i l u r e and c h r o n i c l i v e r d i s e a s e . A new radioimmunoassay 
t e c h n i q u e was used by Lo Gerfo, Krupey and Hanson (1971) 
who d e t e c t e d r a i s e d l e v e l s o f CEA i n most p a t i e n t s w i t h 
adenocarcinoma o f the l a r g e i n t e s t i n e . However, these 
workers a l s o found t h a t serum CEA l e v e l s were e l e v a t e d i n 
p a t i e n t s w i t h p r i m a r y tumours o f o t h e r organs, i n c l u d i n g 
l u n g , p r o s t a t e and b r e a s t . Lo Gerfo e t a l . (1971) proposed 
t h a t t h e i r a n t i s e r u m may r e a c t w i t h a d i f f e r e n t a n t i g e n i c 
s i t e on the CEA molecule t o t h a t used by Thompson and h i s 
c o l l e g u e s (Thompson e t a l . , 1969), and t h a t t h i s s i t e i s 
common t o s e v e r a l d i f f e r e n t types o f tumour c e l l . There was 
a l s o evidence t o suggest t h a t the c a r c i n o e m b r y o n i c a n t i g e n 
system may be heterogenous (von K l e i s t and B u r t i n , 1969; 
Kleinman, H a r w e l l and Turner, 1971). 
The o c currence o f CEA has s i n c e been e x t e n s i v e l y 
if 
i n v e s t i g a t e d i n numerous tumours, v a r i o u s diseased and 
normal t i s s u e s , as w e l l as i n the serum o f such 
i n d i v i d u a l s . I t has been s t u d i e d i n carcinomas o f the l u n g 
(Sehested, H i r s c h and Hou-Jensen, 1 9 8 1 ; Sun, E d g i n g t o n , 
C a r p e n t i e r , McAffee, T e r r y and Bateman, 1 9 8 3 ) ; ovary 
(H e a l d , Buckley and Fox, 1979 ; Takeda, Matsuyama, Kuzuyak, 
Chihara, Tsubouchi and Takeuchi, 1 9 8 4 ) ; i n h y p o p l a s i a and 
adenocarcinoma o f the c e r v i x (Speers, Picaso and 
S i l v e r b e r g , 1 9 8 3 ) ; i n benign (Penneys, N a d j i and Morales, 
1982) and m a l i g n a n t tumours o f sweat glands (Penneys, 
N a d j i , Ziegels-Weissman, K e t a b c h i and Morales, 1 9 8 2 ) ; i n 
normal and h y p e r p l a s t i c t h y r o i d s , and m e d u l l a r y t h y r o i d 
carcinoma ( L l o y d , Sisson and Marangos, 1 9 8 3 ; Calmettes, 
C a i l l o u , Moukhtar, Milhaud and Gerard-Marchant, 1 9 8 2 ) , as 
w e l l as i n normal g a l l b l a d d e r e p i t h e l i u m and a l l 
h i s t o l o g i c a l t y pes o f carcinoma o f t h i s organ 
( Albores-Saavedra, N a d j i , Morales and Henson, 1 9 8 3 ) -
E x f o l i a t e d b l a d d e r tumour c e l l s have a l s o been found t o 
have a wide range o f CEA c o n t e n t (Wahren, E s p o s t i and 
Zimmerman, 1 9 7 7 ) . 
CEA has a l s o been d e t e c t e d i n body f l u i d s , i n c l u d i n g 
the p a n c r e a t i c j u i c e from benign and m a l i g n a n t l y diseased 
pancreata ( T a t s u t a , Yamamura, Yamamoto, Okano, M o r i i , Okuda 
and Tamura, 1 9 8 3 ) , a m n i o t i c f l u i d (Oehr, Bellman and 
Hamann, 1 9 8 2 ) , and the i n f l u i d from benign b r e a s t c y s t s 
( F l e i s h e r , O e ttgen, Breed, Robbins, Pinsky and Schwartz, 
1 9 7 4 ) . 
CEA-related a n t i g e n s , i n c l u d i n g one moiety d i s t i n c t i v e 
f o r CEA, have been d e t e c t e d i n normal a d u l t feces ( K u r o k i , 
Koga and Matsuoka, 1 9 8 1 ) , and CEA has been d e t e c t e d i n the 
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blood o f asymptomatic a d o l e s c e n t s (Tabor, Gerety, Needy, 
E l i s b e r g , Colon and Jones, 1981). E l e v a t e d blood l e v e l s o f 
an a n t i g e n s i m i l a r t o human CEA have even been r e c o r d e d i n 
g o r i l l a s and chimpanzees, (Haagensen, Metzgar, Swenson 
et a l . , 1982). 
Breast cancer 
B r e a s t cancer i s the commonest cancer i n women, 
ca u s i n g over 12,000 deaths a year i n the U.K. a t the 
p r e s e n t t i m e . An i n d i v i d u a l woman has a 1:14 chance o f 
c o n t r a c t i n g t h e disease d u r i n g her l i f e t i m e and i t i s the 
commonest cause o f death amongst women i n the 35-55 age 
group (see Baum, 1981). I n the USA 27% o f a l l m a l i g n a n t 
neoplasms i n women are b r e a s t cancers (see Ruddon, 1981 ) . 
An u n t r e a t e d v i c t i m o f t h i s disease can expect o n l y 17.2% 
of the normal d u r a t i o n o f l i f e (Greenwood, 1926). Among 
women i n the U n i t e d S t a t e s t h e r e has been l i t t l e change i n 
the o v e r a l l death r a t e from 1930 t o 1967 (see Seidman, 
1969), t h i s b e i n g m a i n t a i n e d by s m a l l i n c r e a s e s i n both 
i n c i d e n c e and s u r v i v a l . Breast cancer occurs about 100 
times as f r e q u e n t l y i n women as i n men (Seidman, 1969). 
There i s c o n s i d e r a b l e v a r i a t i o n i n the prog r e s s o f 
cases o f b r e a s t cancer, even i n p a t i e n t s o f the same age, 
w i t h the same d u r a t i o n o f symptoms and w i t h tumours o f 
comparable c l i n i c a l e x t e n t . Women p r e s e n t i n g w i t h t h e 
disease i n an advanced s t a t e and a l o n g h i s t o r y may s u r v i v e 
f o r many years w i t h o n l y l i m i t e d t r e a t m e n t , w h i l s t p a t i e n t s 
who a t t e n d h o s p i t a l e a r l y w i t h what appears t o be o n l y a 
l o c a l i z e d g rowth may d i e o f metastases w i t h i n months o f 
r a d i c a l s u r g e r y and a f u l l course o f p o s t - o p e r a t i v e 
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r a d i o t h e r a p y . Knowledge o f the n a t u r a l h i s t o r y o f cancer 
a f f e c t s t h e r a p e u t i c d e c i s i o n s , and t h i s i s e s p e c i a l l y t r u e 
o f b r e a s t cancer. 
T r a d i t i o n a l l y i t was assumed t h a t a cure f o r b r e a s t 
cancer was p o s s i b l e p r o v i d e d t h a t the disease was c o n f i n e d 
t o the b r e a s t and a x i l l a r y lymph nodes. Syme (1842) 
proposed a h y p o t h e s i s t o e x p l a i n the b i o l o g i c a l behaviour 
o f b r e a s t carcinoma. He wrote "...The r e s u l t o f o p e r a t i o n s 
f o r carcinoma o f the b r e a s t when the glands are a f f e c t e d i s 
almost always u n s a t i s f a c t o r y , however p e r f e c t l y they seem 
t o have been taken away. The reason f o r t h i s i s t h a t t h e 
glan d s do n o t p a r t i c i p a t e i n the disease u n l e s s the system 
i s s t r o n g l y disposed t o i t . . . " . 
F i f t y years l a t e r H a l stead (1907) took a c o n t r a d i c t o r y 
s t a n c e , s t a t i n g "...We b e l i e v e t h a t cancer o f the b r e a s t , 
i n s p r e a d i n g c e n t r i f u g a l l y p r e s e r v e s , i n the main, 
c o n t i n u i t y w i t h t h e o r i g i n a l g r o w t h , and b e f o r e i n v o l v i n g 
the v i s c e r a , may become w i d e l y d i f f u s e d a l o n g s u r f a c e 
p l a n e s . . . " . This second h y p o t h e s i s r a p i d l y became the 
accepted m e d i c a l dogma. 
I n t h e e a r l y p a r t o f t h i s c e n t u r y r a d i c a l mastectomy 
was the t r e a t m e n t o f ch o i c e f o r o p e r a b l e p r i m a r y carcinoma 
of t h e b r e a s t . The common f a i l u r e s o f t h i s approach were 
u s u a l l y e x p l a i n e d as being the r e s u l t o f new cancers r a t h e r 
than o f a f a i l u r e o f s u r g i c a l t e c h n i q u e . 
By the mid 1930s i t was r e c o g n i s e d t h a t r a d i c a l 
mastectomy cured o n l y a m i n o r i t y o f p a t i e n t s , a l t h o u g h 
f a i l u r e s were a s c r i b e d e i t h e r t o the assumption t h a t the 
p a t i e n t d i d not p r e s e n t e a r l y enough, or t o the o p e r a t i o n 
n o t being s u f f i c i e n t l y r a d i c a l (see Baum, 1979). This 
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s i t u a t i o n l e d t o the a d o p t i o n o f s c r e e n i n g programs t o 
f a c i l i t a t e e a r l y d i a g n o s i s , t o the use o f s u p e r - r a d i c a l 
s u r g i c a l t e c h n i q u e s , and t o the use o f r a d i o t h e r a p y i n 
a d d i t i o n t o s u r g i c a l t r e a t m e n t . At the time t h e r e was no 
evidence t o suggest t h a t the i n t r o d u c t i o n o f r a d i c a l 
mastectomy c o n f e r e d any advantage over the more 
c o n s e r v a t i v e t e c h n i q u e s employed b e f o r e H a l s t e a d (see Baum, 
1 9 7 9 ) . 
McWhirter ( 1 9 ^ 8 ) i n t r o d u c e d a t r e a t m e n t program 
c o n s i s t i n g o f a si m p l e mastectomy f o l l o w e d by r a d i o t h e r a p y 
o f t h e a x i l l a , t h e s u p r a c l a v i c u l a r lymph node b e a r i n g areas 
and t he ches t w a l l . T his a u t h o r contended t h a t any improved 
s u r v i v a l o f p a t i e n t s t r e a t e d by r a d i c a l mastectomy was an 
a r t e f a c t a r i s i n g from the process o f p a t i e n t s e l e c t i o n . He 
m a i n t a i n e d t h a t o n l y 56% o f p a t i e n t s were op e r a b l e by 
r a d i c a l s u r g e r y , and t h a t a d o p t i o n o f h i s c o m b i n a t i o n o f 
r a d i o t h e r a p y w i t h l e s s r a d i c a l s u r g e r y would r e s u l t i n 
l o c a l c o n t r o l o f a l a r g e r p r o p o r t i o n o f p a t i e n t s w i t h 
b r e a s t cancer. I t has su b s e q u e n t l y been shown t h a t a d d i t i o n 
o f r a d i o t h e r a p y t o any s u r g i c a l t r e a t m e n t o f b r e a s t cancer 
r e s u l t s i n a lower i n c i d e n c e o f l o c a l or r e g i o n a l 
r e c u r r e n c e . This i s most c l e a r l y seen i n p a t i e n t s w i t h 
i n v o l v e m e n t o f the a x i l l a r y lymph nodes (Weichselbaum, 
Marck and Halman, 1 9 7 6 ; Brady, F l e t c h e r and L e v i t t , 1 9 7 7 ) , 
a l t h o u g h Brady e t a l . ( 1 9 7 7 ) f a i l e d t o demonstrate t h a t 
r a d i o t h e r a p y s i g n i f i c a n t l y improved p a t i e n t s u r v i v a l . I t 
has y e t t o be demonstrated t h a t l o c a l c o n t r o l cannot be 
e q u a l l y w e l l achieved i f r a d i o t h e r a p y i s g i v e n a t the f i r s t 
s i g n o f r e c u r r e n c e . (Easson, 1 9 6 8 ; Chu, L i n , Kim, Hun and 
Garmatis, 1 9 7 6 ; Madoc-Jones, Nelson and Montague, 1 9 7 6 ) . 
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P r o s p e c t i v e randomized t r i a l s were s e t up t o 
i n v e s t i g a t e the e f f e c t o f r a d i o t h e r a p y on s u r v i v a l and the 
use o f l e s s e x t e n s i v e s u r g i c a l p rocedures. These s t u d i e s 
were o f two t y p e s , e i t h e r a comparison o f a r a d i c a l 
s u r g i c a l procedure w i t h a l e s s r a d i c a l s u r g i c a l procedure 
p l u s r a d i o t h e r a p y ( B r i n k l e y and H a y b i t t l e , 1971; H a m i l t o n , 
Langlands and P r e s c o t t , 1974; Burn, 1974;), or a comparison 
o f two groups o f p a t i e n t s i n which the o n l y d i f f e r e n c e i n 
t h e r a p y c o n s i s t e d o f the a d d i t i o n o f r a d i a t i o n . ( F i s h e r , 
S l a c k , Cavanaugh, Gardner and Ravdin, 1970; Easson, 1968). 
I t was concluded t h a t t h e r e was no s t a t i s t i c a l d i f f e r e n c e 
i n s u r v i v a l between p a t i e n t s g i v e n one or a n o t h e r t h e r a p y . 
Numerous c r i t i c i s m s o f these s t u d i e s were made, ( F i s h e r , 
1973), the most i m p o r t a n t being the r e l a t i v e l y s m a l l number 
o f p a t i e n t s i n v o l v e d . 
D e v i t t (1965) suggested t h a t " . . . a x i l l a r y lymph node 
metastases are an •. e x p r e s s i o n o f bad p r o g n o s i s r a t h e r than a 
d e t e r m i n a n t . . . " . This i m p l i e d t h a t women w i t h p r i m a r y 
b r e a s t carcinoma w i t h o u t metastases i n the a x i l l a r y lymph 
nodes may not n e c e s s a r i l y e x h i b i t a c h r o n o l o g i c a l l y e a r l y 
stage o f the d i s e a s e , but a form which i s b i o l o g i c a l l y 
f a v o u r a b l e , the a x i l l a r y nodes h a v i n g s u c c e s s f u l l y 
d e s t r o y e d any cancer c e l l s t h a t a r r i v e d w i t h i n t h e i r 
substance and perhaps p l a y i n g a r o l e i n t h e maintenance o f 
s y s t e m i c immunity. S u r g i c a l removal or r a d i o t h e r a p y o f the 
lymph nodes c o u l d t h e r e f o r e be d e t r i m e n t a l t o the p a t i e n t 
( S t j e r s w a r d , J o n d a l , Vanky, W i g z e l l and Sealy, 1972). I t 
has been s p e c u l a t e d t h a t the lymph nodes may serve as a 
b a r r i e r t o the spread o f metastases (Baum and Coyle, 1977). 
T h e r e f o r e i n r e c e n t years the p o p u l a r h y p o t h e s i s i s a 
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r e s t a t e m e n t o f t h a t proposed by Syme, ( 1 8 4 2 ) , t h a t i n the 
m a j o r i t y o f cases, carcinoma o f the b r e a s t must be a 
systemi c d i s e a s e , however s m a l l the p r i m a r y tumour may 
appear. The magnitude o f the r e s i d u a l tumour burden 
f o l l o w i n g the mastectomy i s i n d i r e c t l y r e f l e c t e d by the 
e x t e n t o f i n v o l v e m e n t o f the a x i l l a r y nodes. The a x i l l a r y 
node i n v o l v e m e n t t h e r e f o r e i s not a d e t e r m i n a n t o f 
p r o g n o s i s but merely a symptom o f the most a g g r e s s i v e forms 
o f t h i s heterogenous disease ( F i s h e r , 1970). T h i s t h e o r y 
b e t t e r f i t s t h e a v a i l a b l e data c o n c e r n i n g the behaviour o f 
e a r l y b r e a s t carcinoma, and s y s t e m i c o p t i o n s o f t h e r a p y are 
now a v a i l a b l e f o r t e s t i n g t h i s h y p o t h e s i s . 
Since 1970 t h r e e i n v e s t i g a t i o n s have been i n i t i a t e d on 
a l a r g e s c a l e t o determine i f s i m p l e removal o f the b r e a s t 
w i l l r e s u l t i n a s u r v i v a l e q u a l t o t h a t o b t a i n e d w i t h more 
e x t e n s i v e s u r g i c a l and r a d i a t i o n t h e r a p y . (Cancer Research 
Campaign Working P a r t y , 1976, 1980; F i s h e r , Montague, 
Redmond e t a l . , 1977; Lythgoe, Leek, S w i n d e l l , 1978). 
T h e i r f i n d i n g s are almost i d e n t i c a l . There are no 
s t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e s i n the s u r v i v a l or i n 
the i n c i d e n c e o f d i s t a n t metastases among p a t i e n t s 
r e c e i v i n g the v a r i o u s t r e a t m e n t s , a l t h o u g h the p a t i e n t s i n 
the Cancer Research Campaign study (1976; 1980) and the 
Manchester study (Lythgoe e t a l . , 1977) who d i d not 
r e c e i v e r a d i o t h e r a p y have a much h i g h e r i n c i d e n c e o f l o c a l 
r e c u r r e n c e . There i s no evidence from these t r i a l s t h a t 
r e g i o n a l r a d i o t h e r a p y produces a syste m i c immunosuppression 
and p r e j u d i c e s s u r v i v a l , or t h a t p a t i e n t s w i t h i n t a c t lymph 
nodes have a b e t t e r s u r v i v a l . 
At p r e s e n t i t i s d i f f i c u l t t o assess s c i e n t i f i c a l l y 
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the c o n t r i b u t i o n o f l o c a l t h e r a p y t o the cure o f p a t i e n t s 
w i t h b r e a s t cancer. No s i n g l e type o f l o c a l t h e r a p y appears 
s u p e r i o r t o a l l o t h e r s , and i t i s not c l e a r t h a t more 
i n t e n s i v e s u r g i c a l procedures or the a d d i t i o n o f r a d i a t i o n 
t o adequate s u r g i c a l t r e a t m e n t improves the w e l f a r e o f most 
p a t i e n t s . I n the m a j o r i t y o f women w i t h cancers a s s o c i a t e d 
w i t h e x t e n s i v e l y i n v o l v e d a x i l l a r y nodes the disease w i l l 
r e l a p s e however r a d i c a l the p r i m a r y t r e a t m e n t ( F i s h e r and 
Sl a c k , 1970; F i s h e r , S l a c k , K a t r y c h and Wolmark, 1975). 
I t i s now a p p r e c i a t e d t h a t b r e a s t cancer i s a disease 
which d i s s e m i n a t e s e a r l y but r e c u r s l a t e , and t h a t l o c a l 
t r e a t m e n t can be expected t o achieve cure o n l y i f i t i s 
a p p l i e d b e f o r e d i s s e m i n a t i o n has taken p l a c e , which 
p r o b a b l y means b e f o r e a b r e a s t lump i s c l i n i c a l l y e v i d e n t . 
B r i n k l e y and H a y b i t t l e , (1975) q u e s t i o n the concept o f cure 
i n b r e a s t cancer, i n t h a t a f t e r twenty y e a r s , a l t h o u g h the 
s u r v i v a l curve o f b r e a s t cancer p a t i e n t s runs p a r a l l e l t o 
the expected s u r v i v a l curve o f a s i m i l a r normal p o p u l a t i o n , 
the p r o b a b i l i t y o f d y i n g from cancer o f the b r e a s t i n t h i s 
group i s s t i l l much g r e a t e r than t h a t i n the normal 
p o p u l a t i o n . 
R e a l i z a t i o n o f the n a t u r e o f t h i s disease has changed 
the o b j e c t i v e s o f l o c a l t r e a t m e n t . The aim now i s t o 
c o n t r o l t h e l o c a l d i s e a s e , p r e v e n t l o c a l r e c u r r e n c e , and 
reduce tumour b u l k , f a c i l i t a t i n g the e f f e c t o f s y s t e m i c 
t h e r a p y . Systemic t h e r a p y i s achieved by hormone 
m a n i p u l a t i o n or c y t o t o x i c chemotherapy and may be 
a d m i n i s t e r e d as an a d j u v a n t , or a t the time o f r e c u r r e n c e . 
The o r i g i n a l concept t h a t e n d o c r i n e t h e r a p y may cause 
r e g r e s s i o n o f advanced b r e a s t cancer was proposed and used 
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i n t r e a t m e n t by Beatson ( 1 8 9 6 ) . I t was based on the known 
method o f m a i n t a i n i n g l a c t a t i o n i n cows by oophorectomy. I t 
remains the p r i m a r y t r e a t m e n t f o r advanced or m e t a s t a t i c 
disease i n pre-menopausal women. 
S c h i n z i n g e r (1889) proposed oophorectomy f o r t r e a t m e n t 
o f p r i m a r y b r e a s t cancer based on the s u p p o s i t i o n t h a t 
post-menopausal b r e a s t a t r o p h y would c o n t a i n the tumour. 
P e l v i c i r r a d i a t i o n was developed as a t e c h n i q u e f o r o v a r i a n 
a b l a t i o n by T a y l o r ( 1 9 3 4 ) , who recommended i t as an 
a d j u v a n t s y s t e m i c t h e r a p y . 
S e v e r a l t r i a l s i n v o l v i n g a d j u v a n t oophorectomy have 
been u n d e r t a k e n , ( T r e v e s , 1957; Nevinny, Nevinny, Rosoff, 
H a l l and Muench, 1967; Ravdin, Lewison, Slack e t a l . , 
1970). Many t r i a l s i n v o l v i n g o v a r i a n i r r a d i a t i o n have a l s o 
been u n d e r t a k e n , (Nissen-Meyer, 1967; Cole, 1970). However, 
because o f inadequate c o n t r o l s or too few people, i t i s not 
c l e a r whether a d j u v a n t oophorectomy or o v a r i a n i r r a d i a t i o n 
w i l l d e l ay r e l a p s e or improve s u r v i v a l f o r p a t i e n t s w i t h 
p r i m a r y b r e a s t cancer. F u r t h e r p r o p e r l y designed t r i a l s are 
needed, p a r t i c u l a r l y i n c o n j u n c t i o n w i t h s t e r o i d r e c e p t o r 
a n a l y s i s . Among l a r g e groups o f p a t i e n t s u n s e l e c t e d except 
f o r menopausal s t a t u s , t h e r e i s p r o b a b l y no m e a n i n g f u l 
d i f f e r e n c e i n r e s p o n s e - r a t e s t o exogenous a d m i n i s t r a t i o n o f 
o e s t r o g e n , oophorectomy, adrenalectomy, or hypophysectomy, 
(see Henderson and C a n e l l o s , 19 8 0 ) . Androgens, 
pr o g e s t e r o n e s and c o r t i c o s t e r o i d s are u s u a l l y r e s e r v e d f o r 
s e c o n d - l i n e t h e r a p y . The b e t t e r response r a t e s t o 
oophorectomy occurs i n premenopausal women and t o 
oestr o g e n s i n p a t i e n t s who are more than f i v e years beyond 
the menopause. Adrenalectomy and hypophysectomy are th o u g h t 
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t o be e f f e c t i v e because they remove p e r s i s t e n t low l e v e l s 
of o e s t r o g e n s , and so p r o b a b l y cause tumour r e g r e s s i o n . 
Newer ty p e s o f en d o c r i n e t h e r a p y i n c l u d e 
a n t i o e s t r o g e n s , ( e . g . Tamoxifen, which i s i n g e n e r a l use 
w i t h few s i d e e f f e c t s ) . A p p r o x i m a t e l y o n e - t h i r d o f p a t i e n t s 
t r e a t e d thus have evidence o f o b j e c t i v e r e g r e s s i o n , 
( W i l l i s , London, Ward, B u t t , Lynch and Rudd, 1977). 
B r e a s t cancer i s known t o be r e s p o n s i v e t o the 
c y t o t o x i c e f f e c t o f many a n t i n e o p l a s t i c agents (see 
Henderson and C a n e l l o s , 1980), i n c l u d i n g d o x o r u b i c i n , 
cyclophosphamide, m e t h o t r e x a t e , t h i o t e p i a , 5 - f l u o r o u r a c i l , 
p h e n y l a l a n i n e mustard, c h l o r a m b u c i l , and v i n c r i s t i n e . I n 
e a r l y c l i n i c a l t r i a l s o f a d j u v a n t chemotherapy, p a t i e n t s 
were g i v e n c y t o t o x i c drugs a t the time o f mastectomy i n 
or d e r t o k i l l any m e t a s t a t i c c e l l s r e l e a s e d i n t o 
c i r c u l a t i o n . Cyclophosphamide f o r s i x days (5mg/kg d a i l y ) 
a f t e r mastectomy was found t o p r o l o n g s u r v i v a l 
s i g n i f i c a n t l y (Nissen-Meyer, K j e l l g r e n , Malmio e t a l . , 
1978). 
The l a r g e number o f en d o c r i n e t r e a t m e n t s and v a r i e t y 
o f drug c o m b i n a t i o n s make the s e l e c t i o n o f a t r e a t m e n t p l a n 
f o r an i n d i v i d u a l p a t i e n t a d i f f i c u l t d e c i s i o n . There have 
been two r e p o r t s o f p a t i e n t s randomized t o r e c e i v e e i t h e r 
chemotherapy or end o c r i n e t h e r a p y , (Nemoto, Rosner, Diaz 
e t a l . , 1978; Pr i e s t m a n , Baum, Jones and Forbes, 1978). I n 
both the response r a t e t o c y t o t o x i c s was h i g h e r , a l t h o u g h 
t h i s was s i g n i f i c a n t o n l y i n the f i r s t s t u d y . 
Chemotherapy i s a s s o c i a t e d w i t h t o x i c i t y , n o t a b l y 
acute nausea, v o m i t i n g , m y e l o s u p p r e s s i o n , t h r o m b o c y t o p e n i a , 
a l o p e c i a and i n c r e a s e d f a t i g a b i l i t y . The e f f e c t s are a l l 
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r e v e r s i b l e when the drug i s d i s c o n t i n u e d . E a r l y s y s t e m i c 
t h e r a p y can t h e o r e t i c a l l y t r e a t metastases b e f o r e they are 
d e t e c t a b l e by methods known a t p r e s e n t , but because o f the 
t o x i c i t y , t h e use o f a d j u v a n t chemotherapy has been l i m i t e d 
t o p a t i e n t s w i t h a x i l l a r y node i n v o l v e m e n t . Methods are 
needed which s e l e c t the groups o f women who may b e n e f i t 
from the c u r r e n t l y a v a i l a b l e s y s t e m i c t h e r a p i e s so as t o 
av o i d the unnecessary t o x i c i t y f o r those who w i l l n o t 
b e n e f i t . P r e d i c t i o n o f e a r l y r e c u r r e n c e i s o f immense v a l u e 
i n a s s e s s i n g the need, and the a p p r o p r i a t e t h e r a p y , f o r 
s e l e c t e d p a t i e n t s a t r i s k . C u t l e r , ( 1 9 6 8 ) , s t a t e s t h a t 
" . . i t i s o n l y t h r o u g h i d e n t i f i c a t i o n and e v a l u a t i o n o f 
f a c t o r s a s s o c i a t e d w i t h v a r i a t i o n i n p a t i e n t s u r v i v a l t h a t 
we can hope t o develop a more r a t i o n a l and more e f f e c t i v e 
approach t o t r e a t m e n t . . " . 
V a r i o u s f a c t o r s are known t o i n f l u e n c e the p r o g n o s i s 
o f p a t i e n t s who are t r e a t e d f o r carcinoma o f the b r e a s t , 
( F o r r e s t , 1971; C u t l e r , 1968). Of p a r t i c u l a r importance i s 
the s t a t u s o f the a x i l l a r y lymph nodes a t the time o f 
mastectomy. However, p a t i e n t s w i t h m e d i a l tumours cannot be 
assessed a d e q u a t e l y , as these tumours d r a i n i n t o t h e 
i n t e r n a l mammary nodes which cannot be sampled a t 
mastectomy. A l s o , once removed, i n v o l v e d nodes no l o n g e r 
p r o v i d e an index o f t h e r a p e u t i c e f f e c t i v e n e s s , and indeed 
some p a t i e n t s w i t h i n v o l v e d nodes may s u r v i v e f o r l o n g 
p e r i o d s . 
Bloom and Richardson, ( 1 9 5 7 ) , d e v i s e d a system t o 
grade the p r i m a r y tumour h i s t o l o g i c a l l y . T h i s i s a g e n e r a l 
i n d i c a t i o n o f whether or not a tumour i s mature or w e l l 
d i f f e r e n t i a t e d . The tumour i s assessed by t h r e e c r i t e r i a : -
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the degree o f s t r u c t u r a l d i f f e r e n t i a t i o n as shown by the 
presence o f t u b u l a r arrangement o f the c e l l s ; v a r i a t i o n i n 
s i z e or shape or s t a i n i n g o f the n u c l e i ; f r e q u e n c y o f 
h y p e r c h r o m a t i c and m i t o t i c f i g u r e s . The p o t e n t i a l 
malignancy o f the tumour i s determined from t he composite 
h i s t o l o g i c a l p i c t u r e . The tumour i s placed i n one o f t h r e e 
grades o f malignancy:- low (Grade I ) , i n t e r m e d i a t e , (Grade 
I I ) , or h i g h , (Grade I I I ) . The p r o g n o s i s o f the p a t i e n t 
worsens as the tumour becomes l e s s w e l l d i f f e r e n t i a t e d . 
The n a t u r e o f m a l i g n a n t b r e a s t e p i t h e l i u m has been 
e x t e n s i v e l y i n v e s t i g a t e d f o r a more s e n s i t i v e marker o f 
disease e x t e n t or f o r some i n d i c a t o r o f tumour b e h a v i o u r . 
One f a c t o r u ndergoing i n t e n s i v e c u r r e n t r e s e a r c h i s the 
presence o f s t e r o i d r e c e p t o r s i n b r e a s t t i s s u e . I t was 
e s t a b l i s h e d t h a t an i m p o r t a n t d i f f e r e n c e between t i s s u e 
which i s dependant upon t h e s y n t h e s i s and s e c r e t i o n o f 
oestrogens by the ovary f o r growth and f u n c t i o n a l a c t i v i t y , 
and non-dependent t i s s u e s , was t h a t such o e s t r o g e n t a r g e t 
t i s s u e ( e g . u t e r u s , vagina or mammary t i s s u e ) were a b l e t o 
c o n c e n t r a t e o e s t r a d i o l . T h i s e f f e c t was found t o be due t o 
i n t r a c e l l u l a r o e s t r o g e n - b i n d i n g r e c e p t o r s . (Jenson, S u z u k i , 
Kawashima, Stumph, J u n g b l u t , and de Sombre, 1968; Jensen 
and de Sombre, 1973). The i m p l i c a t i o n s here are not o n l y 
f o r a n t i - o e s t r o g e n t h e r a p y . The r e p o r t o f one st u d y 
( K n i g h t , L i v i n g s t o n e , Gregory and McGuire, 1977) i n d i c a t e d 
t h a t p a t i e n t s w i t h r e c e p t o r - n e g a t i v e tumours r e c u r r e d 
e a r l i e r . The r e p o r t s o f two r e c e n t s t u d i e s (Maynard, 
Blarney, E l s t o n , H a y b i t t l e and G r i f f i t h s , 1978; Cooke, 
George, S h i e l d s , Maynard and G r i f f i t h s , 1979) i n d i c a t e 
p o t e n t i a l v a l u e o f the o e s t r o g e n r e c e p t o r s t a t u s o f t h e 
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p r i m a r y tumour as a p r o g n o s t i c i n d i c a t o r independent o f 
o t h e r e s t a b l i s h e d f a c t o r s such as lymph node s t a t u s , tumour 
s i z e , or h i s t o l o g i c a l grade. 
Many o t h e r b i o c h e m i c a l "tumour-index" and 
"tumour-marker" substances have been i n v e s t i g a t e d , and 
suggested as p o s s i b l e a i d s i n the management o f p a t i e n t s 
w i t h b r e a s t cancer. 
Purpose o f the p r e s e n t s t u d y 
I t has been r e p o r t e d t h a t a r e l a t i o n s h i p e x i s t s 
between the presence o f CEA i n h i s t o l o g i c a l s e c t i o n s o f 
b r e a s t carcinoma t i s s u e and the subsequent s u r v i v a l o f t h e 
p a t i e n t (Shousa, L y s s i o t i s , Godfrey and Scheuer, 1979). 
Alth o u g h s i m i l a r c l a i m s have been made f o r o t h e r 
carcinomas, (eg. f o r l u n g by Sehested, H i r s c h and 
Hou-Jensen, 1981), the s p e c i a l problems a s s o c i a t e d w i t h 
b r e a s t cancer make t h i s s u g g e s t i o n v e r y i m p o r t a n t . Shousa 
e t a l . ( 1979 ) found t h a t the absence o f CEA from a tumour 
was a s s o c i a t e d w i t h s i g n i f i c a n t l y improved p a t i e n t s u r v i v a l 
a t 5 and 10 y e a r s . However, n o t a l l s t u d i e s have g i v e n t he 
same r e s u l t . Walker (1980) was unable t o demonstrate 
c o r r e l a t i o n between r e c u r r e n c e w i t h i n two years and the 
presence o f CEA i n the tumour. S i m i l a r l y , R o l f Smith, 
H o w e l l , Minawa and M o r r i s o n (1982) d e t e c t e d no r e l a t i o n s h i p 
between CEA occ u r r e n c e i n the p r i m a r y tumour and p a t i e n t 
s u r v i v a l . 
The p r e s e n t s t u d y was t h e r e f o r e undertaken i n an 
a t t e m p t t o c l a r i f y t h e r e l a t i o n s h i p between h i s t o l o g i c a l 
d e m o n s t r a t i o n o f tumour CEA and p a t i e n t s u r v i v a l f o r up t o 
e i g h t years f o l l o w i n g s u r g e r y . The r e l a t i o n s h i p s between 
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tumour CEA and t h e presence o f nodal metastases; 
h i s t o l o g i c a l grade o f the tumour; s i z e o f the tumour, and 
o t h e r f a c t o r s which are known t o i n f l u e n c e t he p r o g n o s i s 
f o r t h i s d i s e a s e , were a l s o i n v e s t i g a t e d . 
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Chapter 2: MATERIALS AND METHODS 
i ) MATERIALS 
Tumour t i s s u e s 
These were a v a i l a b l e from s t o r a g e i n the Department o f 
H i s t o p a t h o l o g y , Dryburn H o s p i t a l , Durham. They had been 
removed a t s u r g e r y , f o r m o l s a l i n e f i x e d , r o u t i n e l y 
processed and wax embedded. 
C l i n i c a l i n f o r m a t i o n 
Case notes were a v a i l a b l e t h r o u g h t he Medical Records 
Department, Dryburn H o s p i t a l . A d d i t i o n a l f o l l o w - u p 
i n f o r m a t i o n was o b t a i n e d t h r o u g h the Radiotherapy 
Department and Cancer R e g i s t e r , Newcastle General H o s p i t a l ; 
the l o c a l R e g i s t r a r o f B i r t h s , Deaths and M a r r i a g e s , and, 
i n some cases t he p a t i e n t s ' g e n e r a l p r a c t i t i o n e r . 
Animals 
Four r a b b i t s o f d i f f e r e n t s t r a i n s were o b t a i n e d 
t h r o u g h , and housed a t the Animal House, Department o f 
Zoology, U n i v e r s i t y o f Durham. They a l l r e c e i v e d a s t a n d a r d 
l a b o r a t o r y d i e t . 
Human CEA 
This (1.3 mg) was the k i n d g i f t o f Dr. G. Rogers, 
Department o f Medical Oncology, Charing Cross H o s p i t a l 
M e d i c a l School, London. I t had been e x t e n s i v e l y p u r i f i e d by 
g e l f i l t r a t i o n and was b e l i e v e d f r e e from n o n - s p e c i f i c 
c r o ss r e a c t i n g a n t i g e n (NCA; Rogers, S e a r l e and Bagshaw, 
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1976; Keep, Leake and Rogers, 1978). 
Immunoglobulins 
Rabbit anti-human CEA ( c o m m e r c i a l ) , s o l u b l e 
h o r s e r a d i s h p e r o x i d a s e - r a b b i t a n t i - p e r o x i d a s e complexes 
(PAP) and p o r c i n e a n t i - r a b b i t immunoglobulins were o b t a i n e d 
from 1Dako' Immunoglobulins, Copenhagen, Denmark. Normal 
p o r c i n e serum was o b t a i n e d e i t h e r from 'Dako' 
Immunoglobulins or from a l o c a l a b a t t o i r . 
S t a i n s and o t h e r r e a g e n t s 
L i g h t green and b a s i c f u c h s i n were o b t a i n e d from 
Hopkins and W i l l i a m s , Chadwell Heath, Essex; a l c i a n b l ue 
8GX from Raymond A. Lamb, Waxes and General S u p p l i e s , 
A l p e r t o n , Middlesex; e o s i n , y e l l o w shade, water s o l u b l e and 
Mayer's h e a m a t o x y l i n CI 75290 from B r i t i s h Drug House L t d . , 
Poole, Dorset; b a c t o t r y p s i n and 'Polywax' from D i f c o 
L a b o r a t o r i e s , D e t r o i t , Michigan; d i a m i n o e t h y l a m i n o e t h a n e 
(DEAE) Sephadex A-50 and d i a m i n o b e n z i d i n e h y d r o c h l o r i d e 
(DAB) from 'Sigma' Chemical Company, Poole D o r s e t , and 
Freud's complete a d j u v e n t from Gibco L a b o r a t o r i e s , New 
York, USA. A l l o t h e r reagents were o f a n a l y t i c a l grade and 
were o b t a i n e d from B r i t i s h Drug House L t d . . 
i i ) PRODUCTION OF ANTI-CEA IMMUNOGLOBULIN 
Immu n i z a t i o n program 
Rabb i t s were immunized w i t h CEA f o l l o w i n g an a d a p t i o n 
o f the schedule o f B u r t i n , von K l e i s t , Sabine and King 
( 1 9 7 3 ) . Normal blood was taken p r i o r t o i m m u n i z a t i o n and 
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i n n o c u l a t i o n s c a r r i e d out a t two-weekly i n t e r v a l s as 
f o l l o w s : 
1) I n t r a c u t a n e o u s i n j e c t i o n o f 0.1 mg of CEA i n complete 
Freud's a d j u v e n t . 
2) Subcutaneous i n j e c t i o n o f 0.05 mg o f CEA i n 0.9% (w/v) 
s a l i n e . 
3) I n t r a v e n o u s i n j e c t i o n o f 0.05 mg CEA i n s a l i n e 
4) I n t r a v e n o u s i n j e c t i o n o f 0.05 mg CEA i n s a l i n e 
5) I n t r a v e n o u s i n j e c t i o n o f 0.025 mg CEA i n s a l i n e 
The r a b b i t s were b l e d v i a a l a t e r a l ear v e i n 10 days 
a f t e r the l a s t i n j e c t i o n . 
Immunoglobulin p u r i f i c a t i o n 
A l l o p e r a t i o n s were performed a t 4 degrees C. The 
blood samples were a l l o w e d t o c l o t and the serum s e p a r a t e d 
by c e n t r i f u g a t i o n . S o l i d ammonium s u l p h a t e was added s l o w l y 
t o the serum t o g i v e a f i n a l c o n c e n t r a t i o n o f 25% (w/v) and 
the serum l e f t s t i r r i n g o v e r n i g h t . P r e c i p i t a t e d p r o t e i n s 
were then removed by c e n t r i f u g a t i o n ( M i s t r a l HS18 
c e n t r i f u g e ; 10,000 g f o r 15 m i n u t e s ) and washed by r e p e a t e d 
r e s u s p e n s i o n i n 1.75 M (23%) ammonium s u l p h a t e . The washed 
p r e c i p i t a t e was then d i s s o l v e d i n a s m a l l volume of 
d i s t i l l e d water and then d i a l y s e d a g a i n s t s e v e r a l changes 
o f d i s t i l l e d w a t e r . L i p o p r o t e i n s , p r e c i p i t a t e d by the low 
i o n i c s t r e n g t h , were removed by c e n t r i f u g a t i o n (10,000 g 
f o r 15 m i n u t e s ) . The s u p e r n a t a n t was then d i a l y s e d a g a i n s t 
50 mM sodium a c e t a t e b u f f e r ( a p p rox. 80 mM sodium a c e t a t e 
a d j u s t e d t o pH 5 w i t h g l a c i a l a c e t i c a c i d and then d i l u t e d 
t o 50 mM sodium a c e t a t e w i t h d i s t i l l e d w a t e r ) , and then 
a g a i n s t d i s t i l l e d water a g a i n . The n o n - d i a l y s a b l e f r a c t i o n 
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was then c e n t r i f u g e d and the s u p e r n a t a n t a g a i n 
e q u i l l i b r a t e d w i t h 50 mM sodium a c e t a t e b u f f e r by d i a l y s i s . 
T h i s was then passed t h r o u g h a 1.6 x 15 cm column o f DEAE 
Sephadex A-50 which had been e q u i l l i b r a t e d w i t h the same 
b u f f e r . The e l u a t e , which corresponds t o t h e IgG f r a c t i o n 
o f the serum was d i a l y s e d a g a i n s t d i s t i l l e d w a t e r , 
l y o p h i l i s e d and s t o r e d d e s i c c a t e d a t -18 degrees C. A f u l l 
account o f t h i s method i s g i v e n by Harbee and I n g i l d 
( 1973). 
P r i o r t o use the a n t i b o d y was absorbed o v e r n i g h t a t 4 
degrees C, and f o r 30 minutes a t 37 degrees C, w i t h human A 
and B e r y t h r o c y t e s as cross r e a c t i o n o f anti-CEA w i t h red 
blood c e l l a n t i g e n s has been observed ( H o l b u r n , Mach, 
Macdonald and Newlands, 197^; Isaacson and Judd, 1977 ) . 
i i i ) HISTOLOGICAL METHODS 
P r e p a r a t i o n o f s e c t i o n s 
A l l t i s s u e b l o c k s were re-embedded i n wax and 5 micron 
s e c t i o n s c u t as r e q u i r e d . 
General h i s t o l o g y 
Heamatoxylin and e o s i n and a l c i a n blue / p e r i o d i c a c i d 
S c h i f f ' s r eagent (PAS) s t a i n e d s e c t i o n s were p r e p a r e d . 
Tumour c l a s s i f i c a t i o n 
The presence o f d u c t a l , l o b u l a r or m e d u l l a r y i n v a s i v e 
carcinoma, and l o b u l a r i n s i t u or i n t r a d u c t a l carcinoma was 
r e c o r d e d , as was the presence o f Padget's d i s e a s e . 
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Tumour d i f f e r e n t i a t i o n 
The tumours were graded a c c o r d i n g t o the Bloom and 
Richardson (1957) system. From t h i s 3 c a t a g o r i e s were 
r e c o g n i z e d : w e l l (3 - 5 o f the above s y s t e m ) , moderately 
w e l l (6 and 7) and p o o r l y (8 and 9) d i f f e r e n t i a t e d . 
Lymphocytic i n f i l t r a t i o n 
T h i s was recorded as none, moderate or e x t e n s i v e . 
Macroscopic appearance o f tumour 
The s i z e o f the tumour and edge d e f i n i t i o n (poor or 
good) was o b t a i n e d from the o r i g i n a l d e s c r i p t i o n . 
CEA l o c a l i s a t i o n 
T h is was performed i m m u n o h i s t o c h e m i c a l l y by the 
p e r o x i d a s e a n t i - p e r o x i d a s e (PAP) t e c h n i q u e (Burns, 1975), a 
m o d i f i c a t i o n o f the method o f S t e r n b e r g e r , Hardy, C u c u l i s 
and Mayer ( 1 9 6 9 ) , as d e t a i l e d below: 
1) Dewaxed, h y d r a t e d s e c t i o n s were t r e a t e d w i t h 2% 
b a c t o t r y p s i n i n 0.2% CaClg f o r 30 minutes a t 20 
degrees C t o expose p r o t e i n s (Curran and Gregory, 
1977, 1978). 
2) A f t e r washing w i t h phosphate b u f f e r e d s a l i n e (PBS), 
0.5% o f H 2 ^ 2 i n a D S ° l u t e methanol was a p p l i e d f o r 30 
minutes t o d e s t r o y any endogenous p e r o x i d a s e a c t i v i t y . 
3) A f t e r washing w i t h PBS the s l i d e s were f l o o d e d w i t h a 
1:10 d i l u t i o n o f normal swine serum (NSS) i n PBS f o r 
30 minutes a t 20 degrees C t o b l o c k any n o n - s p e c i f i c 
b i n d i n g s i t e s f o r IgG. 
4) E i t h e r the p a r t i a l l y p u r i f i e d r a b b i t anti-CEA (0.3 
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mg/ml), or c o n t r o l (non-immune) r a b b i t serum d i l u t e d 
1:40 or the c o m m e r c i a l l y a v a i l a b l e anti-CEA serum 
(1:40) was a p p l i e d t o the s e c t i o n s f o r 30 minutes a t 
20 degrees C. A l l d i l u t i o n s were made i n 5% NSS i n 
PBS. 
5) A f t e r washing w i t h PBS, swine a n t i - r a b b i t 
immunoglobulin serum was a p p l i e d t o the s e c t i o n s a t a 
d i l u t i o n o f 1:100 f o r 30 minutes a t 20 degrees C. 
6) PAP was a p p l i e d a t a d i l u t i o n o f 1:40 f o r 30 minutes a t 
20 degrees C. 
7) The s t a i n was then developed u s i n g DAB i n 50 mM t r i s 
HC1 b u f f e r , pH 7.6 which a l s o c o n t a i n e d 1% H 20 2. The 
pe r o x i d a s e r e a c t s w i t h the DAB t o g i v e a brown s t a i n . 
8) S e c t i o n s were c o u n t e r s t a i n e d w i t h l i g h t green, 
d e h y d r a t e d , c l e a r e d and mounted. 
I n i t i a l l y the c o m m e r c i a l l y a v a i l a b l e anti-CEA was used 
i n t h i s s t a i n i n g s c h edule. However, t h i s a n t i b o d y i s known 
t o be h i g h l y c ontaminated w i t h a n t i b o d y d i r e c t e d a g a i n s t 
NCA (Walker, 1980). NCA i s known t o occur i n normal human 
t i s s u e (von K l e i s t , Chavanel and B u r t i n , 1972) and has been 
found t o have the same c e n t r o g l a n d u l a r l o c a l i z a t i o n as CEA 
i n g a s t r o i n t e s t i n a l tumours ( B u r t i n e t a l . , 1973). I n 
p r e p a r a t i o n i t shares the same e x t r a c t i o n procedure as CEA, 
bei n g f i n a l l y s e p a r a t e d by g e l f i l t r a t i o n (von K l e i s t 
e t a l . , 1972). S e c t i o n s o f normal human s p l e e n , a p o s i t i v e 
c o n t r o l f o r NCA ( B u r t i n , Quan and Sabine, 1975) were 
t h e r e f o r e s t a i n e d u s i n g e i t h e r the a n t i s e r u m o b t a i n e d 
t h r o u g h 'Dako' immunoglobulins or the p a r t i a l l y p u r i f i e d 
r a b b i t anti-CEA prepared by the a u t h o r . The commercial 
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anti-CEA gave e x t e n s i v e r e a c t i o n w i t h these s e c t i o n s , 
w h i l s t the a n t i b o d y prepared i n the l a b o r a t o r y gave no such 
s t a i n i n g (see p l a t e 1 ) . The c o m m e r c i a l l y a v a i l a b l e 
a n t i s e r u m t o CEA was t h e r e f o r e c o n s i d e r e d u n s u i t a b l e f o r 
the p r e s e n t s t u d y , and so the p a r t i a l l y p u r i f i e d r a b b i t 
anti-CEA was used t h r o u g h o u t . 
S p e c i f i c i t y o f s t a i n i n g was checked by a b s o r b i n g t he 
anti-CEA w i t h the CEA o r i g i n a l l y used as the a n t i g e n (0.3 
mg CEA and 0.3 mg anti-CEA i n 1 ml o f phosphate b u f f e r e d 
s a l i n e o v e r n i g h t a t 4 degrees C). When s e c t i o n s known t o be 
p o s i t i v e f o r CEA (human l i v e r and b r e a s t t i s s u e ) were 
s t a i n e d u s i n g t h i s no s t a i n i n g was observed. 
i v ) SELECTION OF CASES FOR INVESTIGATION 
A l l were women p a t i e n t s p r e s e n t e d c o n s e c u t i v e l y a t 
Dryburn H o s p i t a l , between 1st January 1973 and 31st 
December 1975, w i t h p r i m a r y b r e a s t carcinoma. Those who had 
been t r e a t e d p r e v i o u s l y f o r b r e a s t carcinoma and those who 
sub s e q u e n t l y developed carcinoma i n the o t h e r b r e a s t (10 
cases) were wi t h d r a w n . This enabled any r e c u r r e n c e t o be 
a l l o c a t e d t o a p a r t i c u l a r p r i m a r y tumour. Cases where t h e r e 
was no i n v a s i v e component i n the tumuor ( 3) were wi t h d r a w n 
as these have a d i f f e r e n t c l i n i c a l course, and comparisons 
o f s u r v i v a l c o u l d not be made f a i r l y . Three cases where no 
c l i n i c a l i n f o r m a t i o n c o u l d be found were a l s o w i t h d r a w n . 
A f t e r w i t h d r a w a l s 138 cases were i n v e s t i g a t e d . 
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v) ANALYSIS OF DATA 
A l l i n f o r m a t i o n was c o l l e c t e d and recorded onto 
prepared schedules f o r computer a n a l y s i s . Throughout, any 
u n a v a i l a b l e data was recorded as such. A copy o f the 
schedule i s enclosed i n the appendix. The p a t h o l o g i c a l data 
has been d i s c u s s e d . The c l i n i c a l schedule was designed t o 
e s t a b l i s h the p a t i e n t ' s c o n d i t i o n a t the time o f mastectomy 
( 1 s t page), v a r i a t i o n s i n o p e r a t i o n and t r e a t m e n t (2nd 
page) and the response or c l i n i c a l course ( 3 r d page). 
The measurement o f s u r v i v a l i s o f c e n t r a l importance 
i n the s t u d y o f diseases such as cancer, whose outcome i s 
u s u a l l y f a t a l . I n common w i t h most s t u d i e s on s u r v i v a l 
r a t e s f o r cancer the group o f p a t i e n t s p r e s e n t e d here 
r e q u i r e p r o l o n g e d o b s e r v a t i o n o f each p a t i e n t and e x i b i t 
i n c o m p l e t e f o l l o w - u p . That i s , a l a r g e p r o p o r t i o n o f the 
p a t i e n t s are s t i l l a l i v e a t the time o f a n a l y s i s and so i t 
would be i n a p r o p p r i a t e t o i l l u s t r a t e t h e s u r v i v a l r a t e by a 
si m p l e graph showing " p r o p o r t i o n a l i v e " a g a i n s t "time s i n c e 
mastectomy". I n s t e a d s u r v i v a l r a t e i s e s t i m a t e d by the l i f e 
t a b l e or a c t u a r i a l method. This i s a graph showing an 
e s t i m a t e o f the p r o p o r t i o n o f a group o f p a t i e n t s t h a t w i l l 
be a l i v e a t d i f f e r e n t times a f t e r mastectomy, c a l c u l a t e d 
w i t h due allowance f o r i n c o m p l e t e f o l l o w - u p . A p r i n c i p a l 
advantage o f t h i s method i s t h a t i t makes the maximum use 
of a l l s u r v i v a l i n f o r m a t i o n accumulated up t o the c l o s e o f 
the s t u d y . The l i f e t a b l e method was f i r s t d e s c r i b e d i n a 
medi c a l c o n t e x t by Greenwood (1926) and l a t e r by Berkson 
and Gage ( 1 9 5 0 ) , M e r r e l l and Shulman ( 1 9 5 5 ) , C u t l e r and 
Ederer (1958) and Mould ( 1 9 7 6 ) . The method has r e c e n t l y 
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been w e l l e x p l a i n e d i n a r e p o r t t o the Medical Research 
C o u n c i l ' s Leukaemia S t e e r i n g Commitee ( P e t o , P i k e , 
Armitage, Breslow, Cox, Howard, Ma n t e l , McPherson, Peto and 
Smith, 1977) 
An "average" l e n g t h o f s u r v i v a l i s expressed by the 
median s u r v i v a l t i m e , t h a t i s , the l e n g t h o f time r e q u i r e d 
f o r h a l f the p a t i e n t s t o have d i e d , and can be d e r i v e d from 
the l i f e t a b l e by n o t i n g the time a t which t he s u r v i v a l 
curve crosses 50%. Alth o u g h t he median s u r v i v a l time i s 
p r e f e r a b l e t o the mean s u r v i v a l t i m e , which should almost 
never be c i t e d (Berkson and Gage, 1950), median s u r v i v a l 
t i m es can be u n r e l i a b l e u n l e s s the death r a t e around the 
time o f median s u r v i v a l i s h i g h (Peto e t a l . , 1977). 
A comparison o f the s u r v i v a l between any two subgroups 
of p a t i e n t s i s achieved by employing the l o g r a n k t e s t 
( M a n t e l , 1966). This t e s t i n v o l v e s c o u n t i n g the number o f 
deaths i n each subgroup and comparing i t w i t h the e x t e n t o f 
exposure t o r i s k o f death i n t h a t subgroup. The r e s u l t s o f 
the n u m e r i c a l a n a l y s i s i s t o a r r i v e a t a s t a t i s t i c , termed 
c h i - s q u a r e d , which may be compared w i t h an a p p r o p r i a t e 
c h i - s q u a r e d d i s t r i b u t i o n i n o r d e r t o e s t i m a t e a P-value. A 
f u l l account o f t h i s t e c h n i q u e i s g i v e n by Peto e t a l . , 
( 1 9 7 7 ) . The l i f e t a b l e method and l o g r a n k t e s t have been 
employed t o analyse s u r v i v a l i n s t u d i e s o f the 
e f f e c t i v e n e s s o f chemotherapy i n advanced g a s t r i c (Rake, 
M a l l i n s o n , Cocking, Cwynarski, Fox, Wass, D i f f e y and 
Jackson, 1979) and p a n c r e a t i c ( M a l l i n s o n , Rake, Cocking, 
Fox, Cwynarski, D i f f e y , Jackson, Hanley and Wass, 1980) 
cancer. 
A computer program embodying the above t e c h n i q u e s and 
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implemented on an Apple I I microcomputer was used t o 
analyse the n u m e r i c a l data i n the p r e s e n t s t u d y . The a u t h o r 
wishes t o thank Dr. B.L. D i f f e y , Department o f Medical 
P h y s i c s , Dryburn H o s p i t a l , f o r h i s h e l p w i t h t h i s p a r t o f 
the p r o j e c t . 
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P l a t e 1. 
a) S e c t i o n o f spleen s t a i n e d by the PAP t e c h n i q u e u s i n g 
c o m m e r c i a l l y a v a i l a b l e ( D a k o p a t t s ) r a b b i t anti-CEA serum. 
There i s e x t e n s i v e brown s t a i n i n g due t o the r e a c t i o n o f 
t h i s a n t i s e r u m w i t h NCA which i s abundant i n s p l e n i c t i s s u e 
o u t s i d e the lymphoid f o l l i c l e s . 
b) S e c t i o n o f spleen s t a i n e d by the PAP t e c h n i q u e u s i n g the 
prepared IgG f r a c t i o n o f r a i s e d r a b b i t anti-CEA serum. 
There i s no s t a i n i n g r e a c t i o n u s i n g t h i s a n t i s e r u m . 
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P l a t e 2. 
a) Breast t i s s u e - p o s i t i v e c o n t r o l f o r CEA. S t a i n e d by the 
PAP t e c h n i q u e u s i n g the c o m m e r c i a l l y a v a i l a b l e anti-CEA 
serum. 
b) The same b r e a s t t i s s u e s t a i n e d u s i n g the p a r t i a l l y 
p u r i f i e d IgG f r a c t i o n o f the r a i s e d r a b b i t anti-CEA serum. 
L i g h t Green c o u n t e r s t a i n employed i n b o t h . P o s i t i v e 
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Chapter 3: RESULTS 
GENERAL 
The p o p u l a t i o n o f p a t i e n t s i n v e s t i g a t e d i n t h i s s t udy 
had, a t the time o f o p e r a t i o n , an age range o f 29 t o 88 
ye a r s , the mean age being 58.2 years (S.D. 12.43 y e a r s ) . 
They had a mean wei g h t o f 64.32 kg (S.D. 11.20 k g ) , the 
range b e i n g 43 t o 105 kg, w i t h s i x cases unknown. 
Of these 138 cases o f p r i m a r y b r e a s t carcinoma 13 
(9.4%) were o f the i n v a s i v e l o b u l a r v a r i e t y , and one was a 
m e d u l l a r y carcinoma. Of the d u c t a l i n v a s i v e carcinomas 42 
(30%) a l s o had an i n t r a d u c t a l component. 
LOCATION OF CEA. 
The PAP t e c h n i q u e performed upon s e c t i o n s o f p r i m a r y 
b r e a s t carcinoma produced brown p r e c i p i t a t i o n a t the s i t e 
o f CEA o c c u r r e n c e . 
I n w e l l d i f f e r e n t i a t e d carcinomas p o s i t i v e s t a i n i n g , 
when found, was l o c a t e d w i t h i n the lumina o f t u b u l e s and i n 
the l u m i n a l border o f the d u c t a l e p i t h e l i a l c e l l s . I n l e s s 
w e l l d i f f e r e n t i a t e d carcinomas t he s t a i n i n g was d i f f u s e l y 
i n t r a c y t o p l a s m i c i n areas where t he c e l l s formed s o l i d 
groups. 
T y p i c a l CEA l o c a l i z a t i o n i n p r i m a r y b r e a s t carcinomas 
i s i l l u s t r a t e d i n P l a t e s 3 a) and b ) , and 4 a) and b ) . 
CEA was demonstrated i n t i s s u e s e c t i o n s from 60 o f the 
138 cases i n v e s t i g a t e d , ( 4 3 . 5 % ) . 
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P l a t e 3-
a) Case 95 - A d u c t a l i n v a s i v e carcinoma, h i s t o l o g i c a l l y 
Grade 1. Nodal metastases were d e t e c t e d a t mastectomy. 
P a t i e n t d i e d 2yr 2mth a f t e r mastectomy. CEA s t a i n i n g grade 
3+. 
b) Case 141 - A d u c t a l i n v a s i v e carcinoma, h i s t o l o g i c a l l y 
Grade 2. No lymph nodes were found a t mastectomy f o r 
p a t h o l o g i c a l i n v e s t i g a t i o n . P a t i e n t a l i v e and w e l l w i t h no 
r e c u r r e n c e a t Syr post mastectomy. CEA s t a i n i n g grade 3+» 
L i g h t Green c o u n t e r s t a i n employed i n b o t h . P o s i t i v e 
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P l a t e 4. 
a) Case 99 - A d u c t a l i n v a s i v e carcinoma, h i s t o l o g i c a l l y 
Grade 1. No p a t h o l o g i c a l assessment o f lymph node s t a t u s 
was made a t the time o f mastectomy. P a t i e n t a l i v e and w e l l 
w i t h no r e c u r r e n c e a t 8yr p o s t mastectomy. CEA s t a i n i n g 
grade 2+. 
b) Case 92 A d u c t a l l o b u l a r i n v a s i v e carcinoma, 
h i s t o l o g i c a l l y Grade 1. Nodal metastases were found a t the 
time o f mastectomy. P a t i e n t a l i v e and w e l l w i t h no 
r e c u r r e n c e a t 8yr post mastectomy. CEA s t a i n i n g grade 3+. 
L i g h t Green c o u n t e r s t a i n employed i n b o t h . P o s i t i v e 
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OCCURRENCE OF CEA. 
Age and w e i g h t o f p a t i e n t . 
F i g u r e 1 shows the age d i s t r i b u t i o n o f the p o p u l a t i o n 
s t u d i e d , and a l s o the age d i s t r i b u t i o n i n the CEA p o s i t i v e 
s u b - p o p u l a t i o n . The o v e r a l l f r e q u e n c y o f CEA occurrence 
(43.5%) was used t o p r e d i c t an expected number o f CEA 
p o s i t i v e p a t i e n t s w i t h i n each age group. These v a l u e s d i d 
not d i f f e r s i g n i f i c a n t l y ( c h i squared t e s t ) from the 
observed v a l u e s , i n d i c a t i n g t h a t p a t i e n t age had no 
i n f l u e n c e on CEA o c c u r r e n c e . The data f o r w e i g h t 
d i s t r i b u t i o n ( f i g . 2) were t r e a t e d i n the same manner, and 
a g a i n the observed d i s t r i b u t i o n o f CEA p o s i t i v e tumours d i d 
not d i f f e r s i g n i f i c a n t l y from the expected assuming t h a t 
the w e i g h t o f the p a t i e n t i s i n c i d e n t a l . 
Menopausal s t a t u s o f the p a t i e n t . 
The r e l a t i o n s h i p was i n v e s t i g a t e d between the 
f r e q u e n c y o f CEA d e t e c t i o n i n the p r i m a r y tumour t i s s u e and 
the menopausal s t a t u s o f the p a t i e n t a t the time o f 
mastectomy. The r e s u l t s are g i v e n i n t a b l e 1, and show t h a t 
the presence o f CEA i s not r e l a t e d t o the menopausal s t a t u s 
o f the p a t i e n t . 
Size o f the tumour. 
The f r e q u e n c y o f CEA d e t e c t i o n i n the p r i m a r y tumour 
t i s s u e was i n v e s t i g a t e d when the p a t i e n t s were grouped 
a c c o r d i n g t o the s i z e o f t h a t tumour. Table 2 shows t h a t 
t h e r e i s no reason t o suppose t h a t the presence o f CEA i s 
r e l a t e d t o the s i z e o f the tumour. F i g . 3 shows the s i z e 
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d i s t r i b u t i o n o f the tumours examined and o f the CEA 
p o s i t i v e s u b - p o p u l a t i o n . No s i g n i f i c a n t d i f f e r e n c e between 
these d i s t r i b u t i o n s was found. 
Attachment o f the tumour. 
Table 3 shows the r e s u l t s o f the comparison o f the 
frequency o f CEA occurrence when the p a t i e n t s are grouped 
a c c o r d i n g t o any attachment o f t h e i r tumour, e i t h e r t o the 
o v e r l y i n g s k i n or n i p p l e or t o the deep t i s s u e s . No 
r e l a t i o n s h i p between CEA occurrence and attachment o f the 
p r i m a r y tumour was demonstrated. 
Lymphocytic i n f i l t r a t i o n o f the tumour. 
The f r e q u e n c y o f CEA d e t e c t i o n was compared when the 
p a t i e n t s were grouped a c c o r d i n g t o the e x t e n t o f 
l y m p h o c y t i c i n f i l t r a t i o n o f t h e i r tumour, and the r e s u l t s 
are g i v e n i n t a b l e 4. These r e s u l t s show t h a t the presence 
o f CEA i s not r e l a t e d t o l y m p h o c y t i c i n f i l t r a t i o n o f the 
tumour. 
I n t r a d u c t a l component o f the tumour. 
The f r e q u e n c y o f d e t e c t i o n o f CEA i n the p r i m a r y 
tumour was compared when the cases were grouped a c c o r d i n g 
t o t he presence or absence o f i n t r a d u c t a l carcinoma i n the 
tumour t i s s u e . The r e s u l t s g i v e n i n t a b l e 5 show t h a t t he 
frequency o f d e m o n s t r a t i o n o f CEA i s s i g n i f i c a n t l y g r e a t e r 
i n i n v a s i v e tumours which a l s o have an i n t r a d u c t a l 
component ( c h i - s q u a r e d = 4.587, d f = 1 , 0.05>P>0.02). 
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H i s t o l o g i c a l grade o f the tumour. 
The comparison was made between the fr e q u e n c y o f CEA 
d e t e c t i o n i n the p r i m a r y tumour when the cases were grouped 
a c c o r d i n g t o the h i s t o l o g i c a l grade o f d i f f e r e n t i a t i o n o f 
the p r i m a r y tumour, (Bloom and Richardson, 1957). From the 
r e s u l t s shown i n t a b l e 6 i t i s e v i d e n t t h a t the presence 
o f CEA i n the tumour i s not r e l a t e d t o the h i s t o l o g i c a l 
grade o f the tumour. F i g . 4 shows t h e d i s t r i b u t i o n o f 
d i f f e r e n t i a t i o n o f tumours sub-grouped i n t o components o f 
the Bloom and Richardson g r a d i n g system. I t a l s o shows the 
d i s t r i b u t i o n o f the CEA p o s i t i v e s u b - p o p u l a t i o n . These d i d 
not d i f f e r s i g n i f i c a n t l y . 
Lymph node s t a t u s o f the p a t i e n t . 
The frequency o f CEA d e t e c t i o n i n the p r i m a r y tumour 
was compared when the p a t i e n t s were grouped a c c o r d i n g t o 
t h e i r lymph node s t a t u s a t the time o f mastectomy. The 
lymph node s t a t u s was assessed c l i n i c a l l y a t p a t i e n t 
p r e s e n t a t i o n by p a l p a t i o n , and p a t h o l o g i c a l l y by 
m i c r o s c o p i c e x a m i n a t i o n o f a x i l l a r y lymph nodes sampled a t 
the t i me o f mastectomy. The l a t t e r assessment c o u l d not be 
made f o r every case, as a l t h o u g h the p r e s e n t p o l i c y a t 
Dryburn H o s p i t a l i s t o sample the a x i l l a r y lymph nodes a t 
every mastectomy, i n t h i s r e t r o s p e c t i v e s t u d y o n l y 66 o f 
the 138 cases had undergone t h i s i n v e s t i g a t i o n . The r e s u l t s 
do n o t i n d i c a t e t h a t the presence o f CEA i s r e l a t e d t o the 
lymph node s t a t u s o f the p a t i e n t , as assessed c l i n i c a l l y 
( t a b l e 7 ) , or p a t h o l o g i c a l l y f o r the presence o f metastases 
( t a b l e 8 ) , or the number o f m e t a s t a t i c lymph nodes ( t a b l e 
9 ) . 
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SURVIVAL AND THE PRESENCE OF CEA IN THE PRIMARY TUMOUR. 
P a t i e n t s u r v i v a l and the presence o f CEA i n the tumour. 
S u r v i v a l f o l l o w i n g mastectomy was i n v e s t i g a t e d when 
the p a t i e n t s were grouped a c c o r d i n g t o t h e presence or 
absence o f CEA i n t h e i r e x c i s e d tumour. The r e s u l t s are 
summarised i n t a b l e 10. From these r e s u l t s i t i s e v i d e n t 
t h a t the presence o f CEA i n the tumour i s o f no o v e r a l l 
p r o g n o s t i c guide t o s u r v i v a l . This f i n d i n g i s shown 
g r a p h i c a l l y i n f i g . 5 , where i t may be seen t h a t t h e 
s u r v i v a l curves f o r p a t i e n t s w i t h and w i t h o u t CEA i n t h e 
tumour are v i r t u a l l y superimposed. 
The p a t i e n t s were then grouped a c c o r d i n g t o the e x t e n t 
o f CEA occurrence i n the tumour. P a t i e n t s w i t h CEA n e g a t i v e 
or weakly p o s i t i v e tumours (assessed as 0, +/-, +) were 
compared f o r s u r v i v a l w i t h p a t i e n t s who had s t r o n g l y CEA 
p o s i t i v e tumours (++, +++). These r e s u l t s are shown i n f i g . 
6, and t a b l e 11, and i n d i c a t e no s i g n i f i c a n t d i f f e r e n c e 
between these groups. 
S u r v i v a l , CEA and menopausal s t a t u s . 
The r e l a t i o n s h i p o f p a t i e n t s u r v i v a l a c c o r d i n g t o the 
d e t e c t i o n o f CEA i n the p r i m a r y tumour was i n v e s i g a t e d f o r 
p a t i e n t s who were p r e - , p e r i - , and postmenopausal a t the 
time o f mastectomy i n d e p e n d e n t l y . These comparisons are 
summarised i n t a b l e s 12 f o r premenopausal, 13 f o r 
perimenopausal, and 14 f o r postmenopausal p a t i e n t s . The 
r e s u l t s o f f e r no evidence t h a t t h e presence o f CEA i n the 
tumour i s o f p r o g n o s t i c v a l u e w i t h i n any o f these 
s u b c l a s s e s . The s u r v i v a l curves shown i n f i g s . 7 f o r p r e - , 
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8 f o r p e r i - and 9 f o r postmenopausal p a t i e n t s i l l u s t r a t e 
these f i n d i n g s . 
S u r v i v a l , CEA and s i z e o f tumour. 
The r e l a t i o n s h i p o f p a t i e n t s u r v i v a l t o the d e t e c t i o n 
o f CEA i n the p r i m a r y tumour was i n v e s t i g a t e d f o r p a t i e n t s 
w i t h tumours l e s s than 5 cm. d i a m e t e r , and f o r p a t i e n t s 
w i t h tumours o f 5 cm. or g r e a t e r i n d i a m e t e r . The 
comparison o f p a t i e n t s u r v i v a l f o l l o w i n g mastectomy 
a c c o r d i n g t o the presence or absence o f CEA i n the e x c i s e d 
tumour i s summarised i n t a b l e 15 f o r the s m a l l e r tumours, 
and t a b l e 16 f o r the l a r g e r tumours. The s u r v i v a l curves 
are shown i n f i g s . 10 and 11 r e s p e c t i v e l y . The presence o f 
CEA does not appear t o be o f p r o g n o s t i c v a l u e i n groups o f 
p a t i e n t s w i t h l a r g e or s m a l l e r s i z e d p r i m a r y tumours. 
S u r v i v a l , CEA and h i s t o l o g i c a l grade o f tumour. 
The comparison o f p a t i e n t s u r v i v a l f o l l o w i n g 
mastectomy when the cases are grouped a c c o r d i n g t o the 
presence or absence o f CEA i n e x c i s e d , h i s t o l o g i c a l l y grade 
1 tumours i s summarised i n t a b l e 17. A s i m i l a r comparison 
made f o r h i s t o l o g i c a l l y grade 2 tumours i s shown i n t a b l e 
18, and grade 3 tumours i n t a b l e 19. The s u r v i v a l curves 
i l l u s t r a t i n g these r e l a t i o n s h i p s are g i v e n i n f i g s . 12, 13, 
and 14 r e s p e c t i v e l y . These r e s u l t s i n d i c a t e t h a t t he 
presence o f CEA cannot be used as a guide t o s u r v i v a l even 
a f t e r p a t i e n t s have been grouped as h a v i n g w e l l , m o d e r a t e l y 
w e l l , or p o o r l y d i f f e r e n t i a t e d p r i m a r y tumours. 
3? 
S u r v i v a l , CEA and lymph node s t a t u s o f the p a t i e n t . 
The r e l a t i o n s h i p o f p a t i e n t s u r v i v a l t o the d e t e c t i o n 
o f CEA i n the p r i m a r y tumour was i n v e s t i g a t e d f o r p a t i e n t s 
whose lymph node s t a t u s was assessed p a t h o l o g i c a l l y at the 
time o f mastectomy. The comparison o f p a t i e n t s u r v i v a l 
f o l l o w i n g mastectomy w i t h the presence or absence o f CEA i n 
the e x c i s e d p r i m a r y tumour i s summarised i n t a b l e 20 where 
p a t i e n t s are known t o have had m e t a s t a t i c lymph nodes a t 
the time o f mastectomy. Table 21 summarises the same 
comparison f o r p a t i e n t s who were found t o have u n i n v o l v e d 
lymph nodes a t the time o f mastectomy. These r e s u l t s 
i n d i c a t e t h a t the presence o f CEA cannot be used as a guide 
t o p r o g n o s i s i n e i t h e r o f these groups o f p a t i e n t s . F i g . 15 
shows the s u r v i v a l curves f o r CEA d e t e c t i o n i n p a t i e n t s 
w i t h m e t a s t a t i c lymph nodes, and f i g . 16 shows s i m i l a r 
s u r v i v a l curves f o r p a t i e n t s w i t h n o n - m e t a s t a t i c lymph 
nodes. 
S u r v i v a l , CEA and the presence o f i n t r a d u c t a l carcinoma. 
A s i g n i f i c a n t l y g r e a t e r r a t e o f CEA d e t e c t i o n was 
observed i n i n v a s i v e tumours which a l s o possessed an 
i n t r a d u c t a l component, (see t a b l e 5 ) . The r e l a t i o n s h i p o f 
p a t i e n t s u r v i v a l t o the d e t e c t i o n o f CEA i n the p r i m a r y 
tumour was i n v e s t i g a t e d f o r p a t i e n t s who were found t o have 
an i n t r a d u c t a l component t o t h e i r tumour. The r e s u l t s i n 
t a b l e 22, and i l l u s t r a t e d i n f i g . 17 i n d i c a t e t h a t t h e 
presence o f CEA i n i n v a s i v e tumours w i t h an i n t r a d u c t a l 
element does not i n f l u e n c e p a t i e n t s u r v i v a l w i t h i n t h i s 
group. A l s o , the r e s u l t s i n t a b l e 23, shown g r a p h i c a l l y i n 
f i g . 18, i m p l y t h a t t he presence o f CEA i n tumours w i t h o u t 
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an i n t r a d u c t a l component cannot be c o n s i d e r e d t o be a 
p r o g n o s t i c i n d i c a t o r . 
OTHER FACTORS AND PATIENT SURVIVAL. 
P a t i e n t s u r v i v a l and menopausal s t a t u s . 
The comparison o f s u r v i v a l a c c o r d i n g t o the menopausal 
s t a t u s o f the p a t i e n t a t the time o f mastectomy i s 
summarised i n t a b l e 24, and i l l u s t r a t e d g r a p h i c a l l y i n f i g . 
19. These r e s u l t s p r o v i d e no evidence t o suppose t h a t 
s u r v i v a l i s i n f l u e n c e d by the menopausal s t a t u s o f the 
p a t i e n t a t the time o f mastectomy. 
Size o f tumour and p a t i e n t s u r v i v a l . 
S u r v i v a l was compared when the p a t i e n t s were grouped 
a c c o r d i n g t o the s i z e o f the p r i m a r y tumour. The r e s u l t s , 
which are presente d i n f i g . 20, and t a b l e 25, l e a d t o the 
c o n c l u s i o n t h a t p a t i e n t s h a v i n g tumours o f 5 cm. dia m e t e r 
or g r e a t e r a t the time o f mastectomy have a s i g n i f i c a n t l y 
reduced median s u r v i v a l time compared w i t h p a t i e n t s w i t h 
tumours l e s s than 5 cm. di a m e t e r . The c h i - s q u a r e d o b t a i n e d 
f o r the t r e n d was 5.29, g i v i n g a p r o b a b i l i t y o f 0.022. 
P a t i e n t s were grouped a c c o r d i n g t o t h e i r menopausal 
s t a t u s a t the time o f mastectomy, and the s u r v i v a l o f those 
w i t h l a r g e tumours was compared w i t h t h a t o f those w i t h 
s m a l l e r tumours f o r both p r e - ( t a b l e 26, f i g . 21) and 
postmenopausal ( t a b l e 27, f i g . 22) groups. There i s no 
s i g n i f i c a n t d i f f e r e n c e i n e i t h e r group a t the 5% l e v e l 
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(premenopausal, c h i squared=3.03, P=0.082; postmenopausal, 
c h i squared=0.01, P>0.5). However, t a k i n g i n t o 
c o n s i d e r a t i o n the s m a l l numbers i n the c l a s s e s , these 
r e s u l t s c o u l d i m p l y t h a t the s i z e o f the p r i m a r y tumour i s 
o f g r e a t e r i n f l u e n c e on the s u r v i v a l o f premenopausal 
p a t i e n t s than on t h a t o f postmenopausal p a t i e n t s . 
Attachment o f tumour and p a t i e n t s u r v i v a l . 
The comparison o f s u r v i v a l f o l l o w i n g mastectomy when 
p a t i e n t s were grouped a c c o r d i n g t o any the attachment o f 
t h e i r p r i m a r y tumour, e i t h e r t o the o v e r l y i n g s k i n or t o 
the deep t i s s u e s , was made and i s shown i n t a b l e 28. This 
r e l a t i o n s h i p i s shown g r a p h i c a l l y i n f i g . 23. The r e s u l t s 
i m p l y t h a t attachment o f the tumour does not s i g n i f i c a n t l y 
reduce the median s u r v i v a l t i m e . 
Lymphocytic i n f i l t r a t i o n and p a t i e n t s u r v i v a l . 
P a t i e n t s u r v i v a l f o l l o w i n g mastectomy was compared 
when the cases were grouped a c c o r d i n g t o the e x t e n t o f the 
l y m p h o c y t i c i n f i l t r a t i o n o f the p r i m a r y carcinoma. The 
r e s u l t s are summarised i n t a b l e 29, and the s u r v i v a l curves 
are shown i n f i g . 24. No s i g n i f i c a n t d i f f e r e n c e can be 
d e t e c t e d between the median s u r v i v a l times f o r p a t i e n t s 
whose tumours are i n f i l t r a t e d and those whose tumours show 
no l y m p h o c y t i c i n f i l t r a t i o n . (However, the number o f 
p a t i e n t s showing no i n f i l t r a t i o n o f the p r i m a r y tumour i s 
s m a l l , w i t h o n l y 10 cases i n t h i s c l a s s . ) . 
I n t r a d u c t a l component and p a t i e n t s u r v i v a l . 
S u r v i v a l was compared when p a t i e n t s were grouped 
ko 
a c c o r d i n g t o the presence or absence o f an i n t r a d u c t a l 
element i n t h e i r i n v a s i v e carcinomas. Table 30 l i s t s these 
r e s u l t s , and f i g . 25 p r e s e n t s the s u r v i v a l curves f o r these 
two groups. I t can be seen t h a t t h e r e i s no s i g n i f i c a n t 
d i f f e r e n c e i n s u r v i v a l . 
H i s t o l o g i c a l grade o f the tumour and p a t i e n t s u r v i v a l . 
The comparison o f s u r v i v a l when the p a t i e n t s were 
grouped a c c o r d i n g t o the h i s t o l o g i c a l grade o f t h e i r tumour 
i s summarised i n t a b l e 31, and i l l u s t r a t e d g r a p h i c a l l y i n 
f i g . 26. These r e s u l t s s u p p o r t the h y p o t h e s i s t h a t the 
p r o g n o s i s worsens as the tumour becomes l e s s 
w e l l - d i f f e r e n t i a t e d . There i s a s i g n i f i c a n t d i f f e r e n c e 
between the s u r v i v a l o f p a t i e n t s whose tumours are grade 1 
(median s u r v i v a l time >92 months) and those whose tumours 
are grade 3 (median s u r v i v a l time 47 months), w i t h c h i 
squared f o r the t r e n d b e i n g 7.66, g i v i n g a p r o b a b i l i t y o f 
0.005. 
Lymph node s t a t u s and p a t i e n t s u r v i v a l . 
F i n a l l y , s u r v i v a l has been compared f o r p a t i e n t s 
grouped a c c o r d i n g t o t h e i r lymph node s t a t u s a t the time o f 
mastectomy. The r e s u l t s , which are p r e s e n t e d i n t a b l e 32, 
and i l l u s t r a t e d i n f i g . 27, l e a d t o the c o n c l u s i o n t h a t the 
presence o f m e t a s t a t i c disease a t the time o f o p e r a t i o n 
s i g n i f i c a n t l y reduces the median s u r v i v a l t i m e . P a t i e n t s 
w i t h p a t h o l o g i c a l l y determined n e g a t i v e nodes had a median 
s u r v i v a l time o f >90 months, w h i l s t p a t i e n t s w i t h 
p a t h o l o g i c a l l y determined m e t a s t a t i c nodes had a median 
s u r v i v a l t i m e o f 44.9 months. The c h i squared f o r the t r e n d 
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i s 0.47, g i v i n g a p r o b a b i l i t y o f 0.029. No s i g n i f i c a n t 
d i f f e r e n c e was demonstrated i n comparison o f the s u r v i v a l 
o f p a t i e n t s w i t h one or two m e t a s t a t i c lymph nodes, w i t h 
the s u r v i v a l o f p a t i e n t s w i t h t h r e e or more m e t a s t a t i c 
lymph nodes. Table 32 g i v e s these r e s u l t s , and the t r e n d i s 
i l l u s t r a t e d i n f i g . 28. 
k2 
Table 1-: Comparison o f the frequency o f CEA d e t e c t i o n i n 
the p r i m a r y tumour o f p a t i e n t s grouped a c c o r d i n g 
t o t h e i r menopausal s t a t u s . 
Menopausal s t a t u s CEA p o s i t i v e CEA n e g a t i v e 
Pre-menopausal 16 21 
Peri-menopausal 6 6 
Post-menopausal 32 45 
Chi squared = 0.30528 
d f = 2 
0.9 > P > 0.8 
Table 2-: Comparison o f the fre q u e n c y o f CEA d e t e c t i o n i n 
the p r i m a r y tumour o f p a t i e n t s grouped a c c o r d i n g 
t o tumour s i z e . 
Size o f Tumour CEA p o s i t i v e CEA n e g a t i v e 
< 5cm diara. 49 67 
> 5cm diam. 11 11 
Chi squared = 0.45298 
d f = 1 
0.7 > P > 0.5 
Table 3-: Comparison o f fr e q u e n c y o f CEA d e t e c t i o n i n the 
p r i m a r y tumour o f p a t i e n t s grouped a c c o r d i n g t o 
any f i x a t i o n o f t h e i r tumour. 
F i x a t i o n 
Not a t t a c h e d 
Attached 
Chi squared = 2.45871 
d f = 1 
0.9 > P > 0.8 
F i x a t i o n 
A t t a c h e d t o s k i n 
A t t a c h e d t o deep 
t i s s u e 
Chi squared = 0.04751 
d f = 1 
0.9 > P > 0.8 
CEA p o s i t i v e 
35 
25 
CEA p o s i t i v e 
18 
7 
CEA n e g a t i v e 
35 
43 




Table 4-: Comparison o f the fr e q u e n c y o f CEA d e t e c t i o n i n 
th e p r i m a r y tumour o f p a t i e n t s grouped a c c o r d i n g 
t o t he e x t e n t o f l y m p h o c y t i c i n f i l t r a t i o n o f the 
tumour. 
Lymphocytic i n f i l t 
0 
++ 








Chi squared = 0.188194 
d f = 2 
0.95 > P > 0.9 
Table 5-: Comparison o f the f r e q u e n c y o f CEA d e t e c t i o n i n 
p r i m a r y tumours o f p a t i e n t s grouped a c c o r d i n g t o 
th e presence or absence o f an i n t r a d u c t a l element 
i n t he tumour. 
Tumour type CEA p o s i t i v e CEA n e g a t i v e 
I n t r a d u c t a l component 24 18 
No i n t r a d u c t a l component 36 60 
Chi squared = 4.5874 
d f = 1 
0.05 > P > 0.02 
Table 6-: Comparison o f the f r e q u e n c y o f CEA d e t e c t i o n i n 
the p r i m a r y tumours o f p a t i e n t s grouped a c c o r d i n g 
t o t he h i s t o l o g i c a l grade (Bloom and Richardson, 
1957) o f t h e i r tumour. 










Chi squared = 3.55241 
d f = 2 
0.2 > P > 0.1 
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Table 7-: Comparison o f the fr e q u e n c y o f CEA d e t e c t i o n i n 
t h e p r i m a r y tumour o f p a t i e n t s grouped a c c o r d i n g 
t o the presence or absence o f c l i n i c a l l y p a l p a b l e 
lymph nodes a t the time o f mastectomy. 
P a l p a b l e lymph nodes CEA p o s i t i v e CEA n e g a t i v e 
Present 20 18 
Absent 38 58 
Chi squared = 1.88809 
d f = 1 
0.2 > P > 0.1 
Table 8-: Comparison o f the frequency o f CEA d e t e c t i o n i n 
the p r i m a r y tumour where the p a t i e n t s have been 
grouped a c c o r d i n g t o the presence or absence o f 
m e t a s t a t i c a x i l l a r y lymph nodes assessed 
p a t h o l o g i c a l l y a t the time o f mastectomy. 
Lymph node metastases CEA P o s i t i v e CEA Negative 
Present 10 9 
Absent 21 26 
Chi squared = 0.34338 
d f = 1 
0.7 > P > 0.5 
Table 9-: Comparison o f the fr e q u e n c y o f CEA d e t e c t i o n i n 
the p r i m a r y tumour o f p a t i e n t s grouped a c c o r d i n g 
t o number o f m e t a s t a t i c lymph nodes d e t e c t e d 
p a t h o l o g i c a l l y a t the time o f mastectomy. 
No. o f metasteses CEA p o s i t i v e CEA n e g a t i v e 
1 or 2 9 14 
3 or more 12 12 
Chi squared = 0.56140 
d f = 1 
0.5 > P > 0.3 
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Table 10-: Comparison o f s u r v i v a l when p a t i e n t s are grouped 
a c c o r d i n g t o the presence o f CEA i n the p r i m a r y 
tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 78 34 0.01 >0.5 
Detected 60 27 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA n o t d e t e c t e d 87-38 (62.3 t o >92.25) 
CEA d e t e c t e d >92.25 (46.73 t o >92.25) 
Table 11-: Comparison o f s u r v i v a l when p a t i e n t s are grouped 
a c c o r d i n g t o the e x t e n t o f CEA d e t e c t i o n i n the 
p r i m a r y tumour. 
CEA s t a i n i n g N Obs. deaths Chi squared P 
Negative or 
weak p o s i t i v e 
( 0 , +/-, +) 1 12 53 1 .76 0. 185 
S t r o n g p o s i t i v e 
(2+, 3+) 26 8 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA ( 0 , +/-, +) 86.88 (53.77 t o > 92.25) 
2+, 3+ > 92.25 
Table 12-: Comparison o f s u r v i v a l time f o r premenopausal 
p a t i e n t s when grouped a c c o r d i n g t o the presence or 
absence o f CEA i n the p r i m a r y tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 21 9 0.03 >0.5 
Detected 16 7 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
Not d e t e c t e d >92.25 (48.48 t o >92.25) 
Detected >92.25 (39.94 t o >92.25) 
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Table 13-: Comparison o f s u r v i v a l f o r perimenopausal 
p a t i e n t s when graded a c o r d i n g t o the presence or 
absence o f CEA i n the p r i m a r y tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 6 4 0.01 >0.5 
Detected 6 3 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA not d e t e c t e d 62.61 (10.03 t o >83.69) 
CEA d e t e c t e d 53-17 (23.57 t o >83.69) 
Table 14-: Comparison o f s u r v i v a l f o r postmenopausal 
p a t i e n t s when graded a c c o r d i n g t o the presence or 
absence o f CEA i n the p r i m a r y tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 45 19 0.07 >0.5 
Detected 32 14 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA not d e t e c t e d 87.45 (57.66 t o >90.98) 
CEA d e t e c t e d 68.03 (37.42 t o >90.95) 
Table 15-: Comparison o f s u r v i v a l f o r p a t i e n t s w i t h tumours 
<5 cm i n diameter when grouped a c c o r d i n g t o the 
presence or absence o f CEA i n the tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 67 27 0.03 >0.5 
Detected 49 21 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA not d e t e c t e d 87.46 (71.72 t o >92.25) 
CEA d e t e c t e d >92.25 (52.97 t o >92.25) 
Table 16-: Comparison o f s u r v i v a l f o r p a t i e n t s >5 cm i n 
diameter when grouped a c c o r d i n g t o the presence or 
absence o f CEA i n the p r i m a r y tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 11 7 0.47 >0.5 
Detected 11 6 
Median s u r v i v a l t i m e i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA not d e t e c t e d 19.69 (13.7 t o > 8 6 . 1 ) 
CEA d e t e c t e d 40.59 (22.3 t o >86.1) 
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Table 17-: Comparison o f s u r v i v a l f o r p a t i e n t s w i t h grade 1 
h i s t o l o g y when grouped a c c o r d i n g t o the presence 
or absence o f CEA i n the p r i m a r y tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 12 1 0.43 0.498 
Detected 12 3 
Median s u r v i v a l t i m e i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA not d e t e c t e d >88.93 
CEA d e t e c t e d >88.93 
Table 18-: Comparison o f s u r v i v a l f o r p a t i e n t s w i t h Grade 2 
h i s t o l o g y when grouped a c c o r d i n g t o the presence 
or absence o f CEA i n the p r i m a r y tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 50 22 0.47 0.482 
Detected 29 15 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA n o t d e t e c t e d 87.14 (61.18 t o >89-38) 
CEA d e t e c t e d 55.43 (36.33 t o >89.38) 
Table 19-: Comparison o f s u r v i v a l f o r p a t i e n t s w i t h grade 3 
h i s t o l o g y when grouped a c c o r d i n g t o the presence 
or absence o f CEA i n the p r i m a r y tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 16 11 1.5 0.223 
Detected 16 9 
Median s u r v i v a l t i m e i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA d e t e c t e d 19.58 (13-51 t o 86.96) 
CEA not d e t e c t e d 67.96 (37.47 t o >91.05) 
Table 20-: Comparison o f s u r v i v a l f o r p a t i e n t s w i t h lymph 
node metastases d e t e c t e d by h i s t o l o g i c a l 
e x a m i n a t i o n a t the time o f mastectomy, when 
grouped a c c o r d i n g t o the presence or absence of 
CEA i n the p r i m a r y tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 26 18 0.05 >0.5 
Detected 21 15 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA not d e t e c t e d 49.9 (18.25 t o 86.98) 
CEA d e t e c t e d 38.1 (22.46 t o 55.62) 
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Table 2 1 - : Comparison o f s u r v i v a l f o r p a t i e n t s w i t h o u t 
lymph node metastases, by h i s t o l o g i c a l e x a m i n a t i o n 
a t t he time o f mastectomy, when grouped a c c o r d i n g 
t o t he presence or absence o f CEA i n the p r i m a r y 
tumour . 
CEA 








Chi squared P 
0.14 >0.5 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA not d e t e c t e d >87 (22.18 t o >87) 
CEA d e t e c t e d >87 (21.9 t o >87) 
Table 22-: Comparison o f s u r v i v a l o f p a t i e n t s whose p r i m a r y 
tumours c o n t a i n e d an i n t r a d u c t a l carcinoma, when 
grouped a c c o r d i n g t o the presence or absence o f 
CEA i n the tumour. 
CEA N Obs. deaths Chi squared P 
Not d e t e c t e d 18 12 0.61 0.431 
Detected 24 12 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA not d e t e c t e d 53-36 (20.47 t o 71.8) 
CEA d e t e c t e d 67-71 (35-78 t o >92.09) 
Table 23=: Comparison o f s u r v i v a l o f p a t i e n t s whose p r i m a r y 
tumours d i d n o t c o n t a i n an i n t r a d u c t a l component 
when grouped a c c o r d i n g t o the presence or absence 
o f CEA i n the tumour. 
CEA N Obs. deaths Chi squared P 
Detected 60 22 0.24 >0.5 
Not d e t e c t e d 36 15 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
CEA not d e t e c t e d 88.03 (86.93 t o >91.05) 
CEA d e t e c t e d >91.05 (46.46 t o >91.05) 
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Table 24:- Comparison o f s u r v i v a l o f p a t i e n t s grouped 
a c c o r d i n g t o menopausal s t a t u s a t the time o f 
mastectomy. 
Menopausal N Obs . deaths Chi squared P 
s t a t u s 
Pre- 37 16 0.15 >0, .5 
P e r i - 12 7 
Pre- 37 16 0.05 >0. .5 
Post- 77 33 
P e r i - 12 7 0.14 >0. .5 
Post- 77 33 
Median s u r v i v a l time i n months (9 5 % c o n f i d e n c e i n t e r v a l ) 
Premenopausal >92 .25 (50.62 t o >92 .25) 
Perimenopausal 71 .75 (23.1 t o >92. 5) 
Postmenopausal 87 .41 (55.45 t o >92 .25) 
Table 25-: Comparison o f s u r v i v a l o f p a t i e n t s grouped 
a c c o r d i n g t o the s i z e o f the tumour. 
Size o f tumour N Obs. deaths Chi squared P 
>5 cm 22 13 5.29 0.022 
<5 cm 116 48 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
>5 cm 27.93 (19.52 t o >92.25) 
<5 cm 89.05 (67-99 t o >92.25) 
Table 26-: Comparison o f s u r v i v a l when p a t i e n t s , a l l 
premenopausal a t the time o f mastectomy, are 
grouped a c c o r d i n g t o the s i z e o f the p r i m a r y 
tumour. 
Size o f tumour N Obs. deaths Chi squared P 
>5 cm 5 4 3-03 0.082 
<5 cm 32 12 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
>5 cm 25.21 (14.83 t o >92.25) 
<5 cm >92.25 (54.75 t o >92.25) 
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Table 27-: Comparison o f s u r v i v a l when p a t i e n t s , 
postmenopausal a t the time o f mastectomy, are 
grouped a c c o r d i n g t o t h e s i z e o f the p r i m a r y 
tumour. 
Size o f tumour N Obs. deaths Chi squared P 
>5 cm 13 5 0.01 >0.5 
<5 cm 64 28 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
>5 cm >90.98 (19.84 t o >90.98) 
<5 cm 87.32 (54.51 t o >90.98) 
Table 28-: Comparison o f s u r v i v a l o f p a t i e n t s grouped 
a c c o r d i n g t o any attachment o f the p r i m a r y tumour. 
Attachment N Obs. deaths Chi squared P 
None 70 28 1.1 0.297 
To s k i n 50 24 
None 70 28 1.5 0.223 
To deep t i s s u e s 18 9 
To s k i n 50 24 0.09 >0.5 
To deep t i s s u e s 18 9 
Median s u r v i v a l t i m e i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
No attachment 89-19 (66.67 t o >92.25) 
To s k i n 72.18 (47-14 t o >92.09) 
To deep t i s s u e s 53-56 (16.52 t o >92.52) 
Table 29-: Comparison o f s u r v i v a l o f p a t i e n t s grouped 
a c c o r d i n g t o degree o f l y m p h o c y t i c i n f i l t r a t i o n o f 
the tumour. 
Lymphocytic 
I n f i l t r a t i o n N Obs. deaths Chi squared P 
0 10 2 
+ 91 44 
0 10 2 
++ 37 15 
+ 9 1 4 4 




Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
0 >89-38 (52.26 t o >89-38) 
+ 87-09 (53-69 t o >92.25) 
++ >89-38 (46.08 t o >92.25) 
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Table 30-: Comparison o f s u r v i v a l o f p a t i e n t s grouped 
a c c o r d i n g t o the presence or absence o f an 
i n t r a d u c t a l carcinoma i n the tumour. 
I n t r a d u c t a l comp. N Obs. deaths Chi squared P 
Absent 96 37 2.44 0.118 
Present 42 24 
Median s u r v i v a l t i m e i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
I n t r a d u c t a l p r e s e n t 53-38 (37-76 t o >92.25) 
I n t r a d u c t a l absent 88.04 (86.9 t o >92.25) 
Table 3 1 - : Comparison o f s u r v i v a l o f p a t i e n t s grouped 
a c c o r d i n g t o the h i s t o l o g i c a l grade o f the tumour 
(Bloom and Richardson, 1957). 
Grade N Obs. deaths Chi squared P 
1 24 4 5.14 0 -235 
2 79 37 
1 24 4 7.66 0 .005 
3 35 20 
2 79 37 1 .21 0 .237 
3 35 20 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
Grade 1 >92.09 
Grade 2 86.9 (54.04 t o >92.09) 
Grade 3 47-02 (19.44 t o >92.09) 
Table 32-: Comparison o f s u r v i v a l o f p a t i e n t s grouped 
a c c o r d i n g t o t h e i r lymph node s t a t u s a t the time 
o f mastectomy. 
Node s t a t u s N Obs. deaths Chi squared P 
Negative 19 6 0.47 0.029 
P o s i t i v e 47 33 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
N e gative lymph nodes >90.98 (43.84 t o >90.98) 
P o s i t i v e lymph nodes 44.92 (22.17 t o 55.36) 
No. o f i n v o l v e d N Obs. deaths Chi squared P 
nodes 
1 or 2 23 14 1.38 0.242 
> 2 24 19 
Median s u r v i v a l time i n months ( 9 5 % c o n f i d e n c e i n t e r v a l ) 
1 or 2 i n v o l v e d nodes 55.38 (22.25 t o 89-1) 
> 2 i n v o l v e d nodes 27-83 (16.74 t o 51.98) 
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F i g . 1. 
Histogram showing age d i s t r i b u t i o n o f p a t i e n t s 
a t time o f mastectomy, and a l s o showing s u b - p o p u l a t i o n 
w i t h CEA p o s i t i v e tumours. 
22 p SSr&'CEA p o s i t i v e 
11 
l i s 
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Age ( i n y e a r s ) 
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F i g . 2. 
Histogram showing weight d i s t r i b u t i o n o f p a t i e n t s 
a t t i m e o f mastectomy, and a l s o showing s u b - p o p u l a t i o n 
w i t h CEA p o s i t i v e tumours. 










Weight ( i n kg) 
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F i g . 3-
Histogram showing s i z e d i s t r i b u t i o n o f tumours, and 
a l s o showing s u b - p o p u l a t i o n w i t h CEA p o s i t i v e tumours 
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F i g . 4. 
H i s t o g r a m s h o w i n g d i s t r i b u t i o n a c c o r d i n g t o h i s t o l o g i c a l 
s u b - g r a d e o f tumour (Bloom and R i c h a r d s o n , 1 9 5 7 ) , and a l s o 
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H i s t o l o g i c a l s u b - g r a d e o f tu m o u r 
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F i g . 5 . S u r v i v a l c u r v e s f o r p a t i e n t s g r o u p e d a c c o r d i n g 
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F i g . 6. S u r v i v a l c u r v e s f o r p a t i e n t s g r o u p e d a c c o r d i n g 
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F i g . 7 . S u r v i v a l c u r v e s f o r p r e - m e n o p a u s a l p a t i e n t s 
g r o u p e d a c c o r d i n g t o CEA occurrence i n t h e p r i m a r y t u m o u r . 
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F i g . 8. S u r v i v a l c u r v e s f o r p e r i - m e n o p a u s a i p a t i e n t s 
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F i g - 9 . S u r v i v a l c u r v e s l o r p o s t - m e n o p a u s a l p a t i e n t s 
g r o u p e d a c c o r d i n g t o CEA occurrence i n t h e p r i m a r y t u m o u r . 
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F i g . 1 0 . 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h t u m o u r s o f < 5 c m . d i a m e t e r , 
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F i g . 1 1 . 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h t u m o u r s o f > 5 c m . d i a m e t e r , 
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F i g . 1 2 . 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h t u m o u r s o f Grade 1 h i s t o l o g y , 
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F i g . 1 3 . 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h t u m o u r s o f Grade 2 h i s t o l o g y , 
g r o u p e d a c c o r d i n g t o occurrence o f CEA i n t h e p r i m a r y t u m o u r . 
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Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
F i g . 14. 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h t u m o u r s o f Grade 3 h i s t o l o g y , 
g r o u p e d a c c o r d i n g t o occurrence o f CEA i n t h e p r i m a r y t u m o u r . 
100r—. 
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Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
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F i g . 1 5 . 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h lymph node m e t a s t a s e s 
a t t i m e o f m a s t e c t o m y , g r o u p e d a c c o r d i n g t o occurrence o f CEA 
i n t h e p r i m a r y t u m o u r . 
CEA p o s i t i v e 
CEA n e g a t i v e 
Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
F i g . 16. 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h u n i n v o l v e d l ymph nodes 
a t t i m e o f m a s t e c t o m y , g r o u p e d a c c o r d i n g t o occurrence o f CEA 
i n t h e p r i m a r y t u m o u r . 
CEA p o s i t i v e 
CEA n e g a t i v e 
cu 
rt co B t, 










2 4 6 
Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
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F i g . 1 7 . 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h an i n t r a d u c t a l component 
t o t h e i r p r i m a r y t u m o u r when g r o u p e d a c c o r d i n g t o t h e 
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F i g . 1 8 . 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h o u t an i n t r a d u c t a l component 
t o t h e i r p r i m a r y t u m o u r when g r o u p e d a c c o r d i n g t o t h e 
p r e s e n c e o r absence o f CEA i n t h e t u m o u r . 
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64 
F i g . 19. 
S u r v i v a l c u r v e s f o r p a t i e n t s g r o u p e d a c c o r d i n g t o t h e i r 
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F i g . 20. S u r v i v a l c u r v e s f o r p a t i e n t s g r o u p e d a c c o r d i n g 
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F i g . 2 1 . S u r v i v a l c u r v e s f o r p r e - m e n o p a u s a l p a t i e n t s 





















<5cm. max. d i a m . 
>5cm. max. diam 
Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
F i g . 2 2 . S u r v i v a l c u r v e s f o r p o s t - m e n o p a u s a l p a t i e n t s 
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F i g . 23. S u r v i v a l c u r v e s f o r p a t i e n t s g r o u p e d a c c o r d i n g 
t o any a t t a c h m e n t o f t h e p r i m a r y t u m o u r . 
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Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
F i g . 24. S u r v i v a l c u r v e s f o r p a t i e n t s g r o u p e d a c c o r d i n g t o 
l y m p h o c y t i c i n f i l t r a t i o n o f t h e p r i m a r y t u m o u r . 
No l y m p h o c y t i c i n f i l t r a t i o n 
L y m p h o c y t i c i n f i l t r a t i o n + 
L y m p h o c y t i c i n f i l t r a t i o n + + 
Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
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F i g . 2 5 . S u r v i v a l c u r v e s f o r p a t i e n t s g r o u p e d a c c o r d i n g t o 
t h e p r e s e n c e o r absence o f an i n t r a d u c t a l component 
i n t h e i r i n v a s i v e t u m o u r . 
I n t r a d u c t a l c a r c i n o m a p r e s e n t 
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t i g 26. S u r v i v a l c u r v e s f o r p a t i e n t s g r o u p e d a c c o r d i n g 
t o t h e h i s t o l o g i c a l g r a d e o f t h e p r i m a r y t u m o u r . 
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Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
F i g . 27. S u r v i v a l c u r v e s f o r p a t i e n t s g r o u p e d a c c o r d i n g 
t o t h e i r l y m p h node s t a t u s a t t h e t i m e o f m a s t e c t o m y . 
M e t a s t a s e s f o u n d 
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Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
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F i g . 2 8 . 
S u r v i v a l c u r v e s f o r p a t i e n t s w i t h l y mph node m e t a s t a s e s , 
g r o u p e d a c c o r d i n g t o t h e number o f p o s i t i v e l y m p h nodes f o u n d 
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V 
s 
I I I I I » I I I 1 I 
2 4 
Time s i n c e m a s t e c t o m y , ( Y e a r s ) 
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C h a p t e r 4: DISCUSSION 
The p r e s e n t s t u d y has d e m o n s t r a t e d CEA by t h e PAP 
t e c h n i q u e i n 43-5% ( 6 0 / 1 3 8 ) o f t h e c a s e s i n v e s t i g a t e d . No 
r e l a t i o n s h i p c o u l d be d e t e c t e d between t h e o c c u r r e n c e o f 
CEA i n t h e p r i m a r y t u m o u r and t h e age, w e i g h t , m e n o p a u s a l 
s t a t u s o r t h e l y m p h node s t a t u s o f t h e p a t i e n t a t t h e t i m e 
o f m a s t e c t o m y , o r w i t h t h e s i z e , a t t a c h m e n t , l y m p h o c y t i c 
i n f i l t r a t i o n o r h i s t o l o g i c a l g r a d e o f t h e t u m o u r . A 
s i g n i f i c a n t l y g r e a t e r number o f CEA p o s i t i v e c a s e s was 
d e t e c t e d f o r t u m o u r s w h i c h c o n t a i n e d an i n t r a d u c t a l e l e m e n t 
i n a d d i t i o n t o t h e i n v a s i v e c a r c i n o m a t h a n f o r t h o s e where 
i n t r a d u c t a l c a r c i n o m a was n o t a component o f t h e t u m o u r . No 
r e l a t i o n s h i p was f o u n d between t h e o c c u r r e n c e o f CEA i n t h e 
p r i m a r y t u m o u r and s u r v i v a l o f t h e p a t i e n t f o r up t o e i g h t 
y e a r s a f t e r m a s t e c t o m y , and t h i s r e m a i n e d t h e case when 
d e f i n e d s u b - p o p u l a t i o n s o f p a t i e n t s were i n v e s t i g a t e d t o 
e x c l u d e t h e p o s s i b i l i t y t h a t o t h e r p r o g n o s t i c f a c t o r s may 
mask o r b i a s any r e l a t i o n s h i p o f CEA d e t e c t i o n and 
s u r v i v a l . 
I t was shown i n t h i s s t u d y t h a t s u r v i v a l was 
s i g n i f i c a n t l y i n f l u e n c e d by t h e s i z e and t h e h i s t o l o g i c a l 
g r a d e o f t h e t u m o u r , and t h e p r e s e n c e o f m e t a s t a t i c d i s e a s e 
i n t h e a x i l l a r y l y m p h nodes o f t h e p a t i e n t a t t h e t i m e o f 
m a s t e c t o m y . The m e nopausal s t a t u s o f t h e p a t i e n t a t t h e 
t i m e o f m a s t e c t o m y , t h e p r e s e n c e o f i n t r a d u c t a l c a r c i n o m a , 
a t t a c h m e n t o r l y m p h o c y t i c i n f i l t r a t i o n o f t h e t u m o u r a r e 
f a c t o r s w h i c h , i n t h i s s e r i e s , c a n n o t be shown t o a f f e c t 
s i g n i f i c a n t l y t h e s u r v i v a l o f p a t i e n t s . 
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The o v e r a l l o ccurrence o f CEA i n p r i m a r y carcinomas o f 
the b r e a s t determined by o t h e r workers has v a r i e d from 0/12 
and 1/62 by Goldenburg and h i s co-workers (Goldenburg, 
Sharkey and Primus, 1976; 1978) u s i n g PAP and p e r o x i d a s e 
t e c h n i q u e s r e s p e c t i v e l y , t o 10/12 by Heyderman and Munro 
N e v i l l e ( 1977 J, a l s o u s i n g an immunoperoxidase t e c h n i q u e . 
Shousha e t a l . , ( 1 9 7 9 ) , by the same immunoperoxidase 
t e c h n i q u e found 80% o f 69 cases t o be CEA p o s i t i v e . 
Kuhajda, O f f u t t and Mendelsohn ( 1 9 8 3 ) , a g a i n u s i n g 
p e r o x i d a s e , demonstrated CEA i n 68% of the 93 cases o f 
b r e a s t carcinoma i n v e s t i g a t e d , and R o l f Smith and 
co-workers ( R o l f Smith, H o w e l l , Minawa and M o r r i s o n , 1982) 
found 179/290 (62%) o f the p r i m a r y tumours they 
i n v e s t i g a t e d by t h i s t e c h n i q u e t o be CEA p o s i t i v e . Walker 
(1980) demonstrated CEA i n 45/90 b r e a s t carcinomas a l s o 
u s i n g the p e r o x i d a s e method. Using an immunofluorescence 
t e c h n i q u e on needle b i o p s i e s o f p r i m a r y b r e a s t tumours, 
21/50 (42%) showed CEA c o n t a i n i n g c e l l s i n the tumour, and 
these r e s u l t s were c o n f i r m e d u s i n g radioimmunoassay (RIA) 
o f tumour e x t r a c t s (Wahren, L i d b r i n k , W a l l g r e n , Eneroth and 
Z a j i c e k , 1978). Immunohistochemical s t a i n i n g (PAP) was 
performed upon c u l t u r e d e x p l a n t s o f h i s t o l o g i c a l l y proven 
b r e a s t carcinomas by M i l l e r and co-workers, ( M i l l e r , 
Sturgeon and Walker, 1983), i n experiments on the d e t e c t i o n 
and q u a n t i t a t i v e r e l e a s e o f CEA. They o b t a i n e d p o s i t i v e 
s t a i n i n g i n 34/54 (63%) c a n c e r s , and found 41 (76%) t o 
c o n t a i n measurable amounts i n r e p l i c a t e c u l t u r e s by RIA. 
Work on c y t o s o l s from b r e a s t carcinomas ( D u f f y , 0 ' C o n n e l l , 
O ' S u l l i v a n , McKenna, A l l e n and McDonnell, 1983) a l s o by RIA 
found "CEA-like m a t e r i a l " i n 51/62 (82%) tumours. 
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These v a r i a t i o n s i n i n c i d e n c e o f CEA d e t e c t i o n are 
a t t r i b u t a b l e not o n l y t o the d i f f e r e n t t e c h n i q u e s used, but 
a l s o t o the d i f f e r e n c e s i n the a n t i s e r a employed. The 
c h a r a c t e r o f the a n t i s e r u m i s c r i t i c a l i n immunodetection 
s t u d i e s . The r e l a t e d a n t i g e n NCA has a l r e a d y been mentioned 
(Ch.2) but the s i g n i f i c a n c e o f t h i s g l y c o p r o t e i n and the 
c h a r a c t e r o f anti-CEA a n t i s e r a should be d i s c u s s e d i n more 
d e t a i l . 
von K l e i s t and B u r t i n (1969) r e p o r t e d t h a t p e r c h l o r i c 
a c i d e x t r a c t s o f tumour t i s s u e (as used i n the p r e p a r a t i o n 
o f CEA f o r a n t i b o d y p r o d u c t i o n ) c o n t a i n s e v e r a l normal 
t i s s u e p r o t e i n s . Work by Kleinman, H a r w e l l and Turner, 
( 1 9 7 1 ) , who prepared a n t i s e r a t o e x t r a c t s o f c o l o n i c 
adenocarcinomata w i t h p e r c h l o r i c a c i d , demonstrated two 
p r e c i p i t a t i o n l i n e s on i m m u n o d i f f u s i o n . I t was suggested 
t h a t two a n t i g e n s were e x t r a c t e d , and, as these were not 
s e p a r a t e d by g e l f i l t r a t i o n on Sephadex G200, t h a t these 
a n t i g e n s must be o f s i m i l a r s i z e . 
A g l y c o p r o t e i n was then c h a r a c t e r i z e d which was 
p r e s e n t i n normal human t i s s u e , and was n e i t h e r organ or 
tumour s p e c i f i c , and c r o s s - r e a c t e d w i t h CEA (von K l e i s t 
e t a l . , 1972). They termed t h i s g l y c o p r o t e i n N o n s p e c i f i c 
C r o s s r e a c t i n g A n t i g e n (NCA). The same workers found NCA t o 
have the same c e n t r o g l a n d u l a r l o c a t i o n as CEA i n cancerous 
and non cancerous c o l o n i c and g a s t r i c mucosae ( B u r t i n 
e t a l . , 1973), and l a t e r produced a s p e c i f i c anti-NCA 
a n t i s e r u m which i d e n t i f i e d many NCA p o s i t i v e c e l l s o u t s i d e 
the lymphoid f o l l i c l e s i n s e c t i o n s o f s p l e e n . ( B u r t i n , Quan 
and Sabine, 1975). 
Other workers (Kuo, Rosai and T i l l a c k , 1973) i s o l a t e d 
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g l y c o p r o t e i n s from membrane p r e p a r a t i o n s o f b r e a s t 
carcinomas. They found a CEA-like a n t i g e n s h a r i n g a n t i g e n i c 
d e t e r m i n a n t s w i t h CEA, and termed i t Breast Cancer Glyco 
P r o t e i n (BCGP). 
Isaacson and Judd (1977) found t h a t the 
c r o s s - r e a c t i v i t y o f anti-CEA w i t h RBCs, v a s c u l a r 
e n d o t h e l i u m and Paneth c e l l g r a n u l e s c o u l d be e l i m i n a t e d 
w i t h p e r i o d i c a c i d , (a procedure i n c o r p o r a t e d i n t o the 
p r e s e n t s t u d y ) , i m p l y i n g t h a t the a n t i g e n i c d e t e r m i n a n t s 
shared w i t h o t h e r g l y c o p r o t e i n s belong t o the c a r b o h y d r a t e 
p o r t i o n . Holburn e t a l . (197*0 u s i n g 1 2 5 I - l a b e l l e d CEA and 
blood group a n t i b o d i e s concluded t h a t the d e t e r m i n a n t s o f 
A, B and Lewis a n t i g e n s and o f CEA share the same 
g l y c o p r o t e i n c a r r i e r m o l e c u l e s . ( A c c o r d i n g l y , t he a n t i s e r u m 
employed i n the p r e s e n t s t u d y was absorbed w i t h A and B 
e r y t h r o c y t e s b e f o r e u s e . ) . 
Ormerod (1978) employed RIA t e c h n i q u e s w i t h d i f f e r e n t 
a n t i g e n a d d i t i o n t o produce i n h i b i t i o n curves from which he 
demonstrated the e x i s t e n c e o f a t l e a s t f i v e d i s t i n c t 
a n t i g e n i c d e t e r m i n a n t s , e s t a b l i s h i n g t h r e e on p r o t e i n and 
two on the c a r b o h y d r a t e p o r t i o n , one o f which i s shared 
w i t h NCA (termed CEX by t h i s a u t h o r ) . 
K e s s l e r , S h i v e l y , P r i t c h a r d and Todd (1978) i s o l a t e d 
and c h a r a c t e r i z e d a t u m o u r - e x t r a c t e d , CEA-related a n t i g e n 
"TEX". L a t e r c l a i m s were made t h a t t h i s a n t i g e n was 
s u p e r i o r t o CEA as a tumour marker f o r b r e a s t and o t h e r 
c a n c e r s , ( S h i v e l y , Spayth, Chang, M e t t e r , K l e i n , Presant 
and Todd, 1982). 
The evidence f o r "CEA" being a term f o r a heterogenous 
f a m i l y o f r e l a t e d g l y c o p r o t e i n s w i t h shared as w e l l as 
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d i s t i n c t i v e a n t i g e n i c d e t e r m i n a n t s i s reviewed by A l p e r t 
(1978) . 
An i m m u n o l o g i c a l comparison o f CEA e x t r a c t e d from 
tumours o f v a r i o u s organs i n c l u d i n g c o l o n and o v a r y , and 
from p l e u r a l and a s c i t i c f l u i d o f p a t i e n t s w i t h cancer o f 
the pancreas, l u n g and b r e a s t (Lamerz and B u r t i n , 19 8 3) , 
found no evidence f o r organ s p e c i f i c i t y o f CEA. Other 
a u t h o r s (Rogers, Rawlins, Keep, Cooper and Bagshawe, 1981) 
have suggested t h a t d i f f e r e n t i m m u n o l o g i c a l forms of CEA 
may be expressed i n the course o f tumour p r o g r e s s i o n . This 
work employed the double a n t i b o d y RIA t e c h n i q u e , u s i n g a 
mouse monoclonal anti-CEA which r e c o g n i s e d CEA i n p a t i e n t s 
w i t h a v a r i e t y o f s o l i d tumours, t o measure CEA i n human 
serum. However, no p r o g n o s t i c v a l u e was d e t e c t e d , 
s u g g e s t i n g t h a t a l t h o u g h e x p r e s s i o n may vary w i t h tumour 
p r o g r e s s i o n , i t may not correspond t o such p r o g r e s s i o n . 
The a n t i s e r a employed i n the p r e v i o u s l y mentioned 
s t u d i e s c o n c e r n i n g the frequency o f CEA d e t e c t i o n i n b r e a s t 
tumours were o f v a r i o u s sources. D u f f y e t a l . (1983) used a 
commercial a n t i s e r u m , but r e c o g n i s e d the l i m i t a t i o n s o f 
t h i s i n d e s c r i b i n g a "CEA-like m a t e r i a l " . Shousha et a l . 
(1979) . however, make no such d i s t i n c t i o n a l t h o u g h the 
a n t i s e r u m they employed ( D a k o p a t t s ) i s known t o be 
contaminated w i t h an a n t i b o d y d i r e c t e d t o NCA (Walker, 
1980; p r e s e n t s t u d y , Ch. 2 ) . Kuhajda e t a l . (1983) a l s o 
employed the Dakopatts commercial a n t i s e r u m and comment 
t h a t "the r e s u l t s must be i n t e r p r e t e d i n the l i g h t o f 
tumour marker h e t e r o g e n e i t y and v a r i a b i l i t y i n both CEA and 
anti-CEA s e r a " . I n g e n e r a l these s t u d i e s r e s u l t e d i n h i g h e r 
frequences o f d e t e c t i o n . I n s t u d i e s u s i n g t h i s commercial 
75 
a n t i s e r u m (Walker, 1980; M i l l e r e t a l . , 1983; R o l f Smith 
e t a l . , 1982), a t t e m p t s were made t o a b o l i s h t h e anti-NCA 
a c t i v i t y by a b s o r b i n g the a n t i s e r u m w i t h p e r c h l o r i c a c i d 
t r e a t e d e x t r a c t s o f human s p l e e n . Wahren e t a l . (1978) 
c l a i m e d no d e t e c t a b l e r e a c t i o n t o normal c r o s s - r e a c t i v e 
a n t i g e n . The p a r t i a l l y p u r i f i e d anti-CEA used i n t h i s study 
(as p r e v i o u s l y d i s c u s s e d ) was b e l i e v e d t o r e a c t o n l y w i t h 
CEA and r e a c t e d i n comparable frequency t o these s t u d i e s . 
Two r e p o r t e d f i n d i n g s are a p p a r e n t l y out o f consensus. 
Goldenburg e t a l . (1976; 1978) who a l s o used a b s o r p t i o n 
t e c h n i q u e s t o remove a c t i v i t y t o what was termed C C A - I I I i n 
two s e r i e s f a i l e d t o demonstrate s t a i n i n g i n b r e a s t cancer 
i n a l l but one i n s t a n c e , but succeeded i n tumours o f the GI 
t r a c t , bronchus, ovary and c e r v i x . Heyderman and Munro 
N e v i l l e (1977) employed an absorbed goat anti-CEA serum 
which d e t e c t e d a h i g h p r o p o r t i o n o f CEA p o s i t i v e cases i n 
b r e a s t cancer, however, o n l y 12 cases were i n v e s t i g a t e d . 
No r e f e r e n c e has been made i n p r e v i o u s r e p o r t s t o 
i n v e s t i g a t i o n s i n t o the r e l a t i o n s h i p between t he frequency 
o f CEA occurrence i n the p r i m a r y tumour and the w e i g h t o f 
the p a t i e n t w i t h b r e a s t d i s e a s e a t the time o f mastectomy, 
or the attachment o f the tumour. The pr e s e n t study d e t e c t e d 
no r e l a t i o n s h i p . 
Kuhajda e t a l . (1983) found no c o r r e l a t i o n between CEA 
occurrence and the age o f the p a t i e n t or the s i z e o f the 
tumour. R o l f Smith e t a l . (1982) found no r e l a t i o n s h i p 
between CEA occurrence and the s i z e o f the tumour e i t h e r . 
The p r e s e n t study found no r e l a t i o n s h i p between CEA 
occurrence and the age o f the p a t i e n t , or s i z e o f the 
tumour. 
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The frequency o f CEA o c c u r r e n c e , e i t h e r i n the p r i m a r y 
tumour or i n lymph node metastases, was compared a c c o r d i n g 
t o the menopausal s t a t u s o f the p a t i e n t by R o l f Smith and 
co-workers ( 1 9 8 2 ) , and no c o r r e l a t i o n was found. The 
p r e s e n t study s u p p o r t s t h i s f i n d i n g f o r p r i m a r y tumours. 
Walker ( 1980) demonstrated no r e l a t i o n s h i p between the 
presence o f CEA and the e x t e n t o f l y m p h o c y t i c i n f i l t r a t i o n 
o f t he tumour, and no r e l a t i o n s h i p c o u l d be d e t e c t e d i n 
t h i s p r e s e n t i n v e s t i g a t i o n . However, D u f f y e t a l . (1983) 
found an i n v e r s e c o r r e l a t i o n o f l y m p h o c y t i c i n f i l t r a t i o n 
and l e v e l s o f "CEA-like m a t e r i a l " i n c y t o s o l s from p r i m a r y 
b r e a s t tumours. 
No s i g n i f i c a n t c o r r e l a t i o n between CEA and the 
h i s t o l o g i c a l type o f the tumour was d e t e c t e d by Walker 
( 1980) , f i n d i n g no d i f f e r e n c e between the p r o p o r t i o n 
p o s i t i v e i n i n f i l t r a t i n g d uct and i n f i l t r a t i n g l o b u l a r 
carcinomas. S i m i l a r c o n c l u s i o n s were drawn by Shousha and 
L y s s o i t i s ( 1978), and D u f f y e t a l . (1983) - Wahren ( 1978) 
found no c o r r e l a t i o n w i t h the c y t o l o g i c a l t y p e . Kuhajda and 
co-workers (1983) found i n t r a d u c t a l and i n f i l t r a t i n g d u c t 
carcinomas were more o f t e n p o s i t i v e f o r CEA than were 
i n s i t u l o b u l a r and i n f i l t r a t i n g l o b u l a r , but no 
s i g n i f i c a n t d i f f e r e n c e between i n s i t u l o b u l a r and 
i n f i l t r a t i n g l o b u l a r , or between i n t r a d u c t a l and 
i n f i l t r a t i n g d uct carcinoma. However, they observed t h a t 
the s t r o n g e s t s t a i n i n g was o f t e n seen i n the i n t r a d u c t a l 
component ( o r a t the advancing edge of the t u m o u r ) . From a 
" d i l u t i o n a l immunoperoxidase s t u d y " o f CEA employing the 
commercial a n t i s e r u m , Wells and H a s l e t o n (1981) suggested 
t h a t as an i n t r a d u c t l e s i o n becomes i n v a s i v e i t l o s e s i t s 
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a b i l i t y t o s y n t h e s i z e or s t o r e CEA. The a n t i s e r u m employed 
i n t h i s work l a c k s s p e c i f i c i t y , and t h e r e i s no mention o f 
numbers o f cases i n v e s t i g a t e d . The p r e s e n t study found a 
s i g n i f i c a n t l y g r e a t e r p r o p o r t i o n o f cases p o s i t i v e f o r CEA 
i n i n v a s i v e tumours which a l s o c o n t a i n e d an i n t r a d u c t a l 
component than i n i n v a s i v e tumours w i t h o u t i n t r a d u c t a l 
carcinoma. No i n v e s t i g a t i o n was made i n t o pure i n t r a d u c t a l 
carcinomas due t o these p r o d u c i n g a very d i f f e r e n t c l i n i c a l 
course i n a study concerned p r i m a r i l y w i t h s u r v i v a l . 
The p r e s e n t study d e t e c t e d no r e l a t i o n s h i p between the 
occu r r e n c e o f CEA i n t h e pr i m a r y tumour and the 
h i s t o l o g i c a l grade. This i s i n agreement w i t h the f i n d i n g s 
o f Wahren e t a l . ( 1 9 7 8 ) , R o l f Smith e t a l . ( 1 9 8 2 ) , and the 
f i n d i n g s o f D u f f y e t a l . (1983) f o r CEA-like m a t e r i a l i n 
c y t o s o l s from b r e a s t carcinomas. This l a t t e r i n v e s t i g a t i o n , 
however, found t h a t when o n l y c o n s i d e r i n g tumours w i t h o u t , 
or w i t h very l i t t l e l y m p h o c y t i c i n f i l t r a t i o n , 
c o n c e n t r a t i o n s o f the CEA-like m a t e r i a l c o r r e l a t e d w i t h 
grade. Only 10 tumours were assessed as h a v i n g "0" 
l y m p h o c y t i c i n f i l t r a t i o n i n t h i s c u r r e n t s t u d y , n o t 
a l l o w i n g a s i m i l a r comparison. I n the study by D u f f y e t a l . 
( 1983)? d i f f e r e n t i a t i o n was assessed a c c o r d i n g t o the 
frequency o f m i t o t i c f i g u r e s , a m o d i f i c a t i o n o f the Bloom 
and Richardson (1957) system o f assessment. Walker ( 1 9 8 0 ) , 
u s i n g t h i s same m o d i f i c a t i o n o f assessment, d e t e c t e d an 
apparent r e l a t i o n s h i p between h i s t o l o g i c a l d i f f e r e n t i a t i o n 
and t he presence o f CEA, but a l t h o u g h the c h i - s q u a r e d t e s t 
g i v e s a s i g n i f i c a n t P v a l u e from t he numbers g i v e n i n the 
a p p r o p r i a t e t a b l e , the t o t a l s quoted i n the t a b l e f o r CEA 
p o s i t i v e and n e g a t i v e do not q u i t e correspond t o the 
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numbers g i v e n p r e v i o u s l y f o r CEA p o s i t i v e and n e g a t i v e 
cases. 
There are c o n f l i c t i n g r e s u l t s from p r e v i o u s s t u d i e s 
c o n c e r n i n g the s i g n i f i c a n c e o f CEA occurrence i n the 
p r i m a r y tumour and synchronous lymph node metastases i n the 
p a t i e n t . Shousha and L y s s i o t i s (1978) r e p o r t e d a d i s t i n c t 
c o r r e l a t i o n between the h i s t o l o g i c a l d e m o n s t r a t i o n o f CEA 
and the presence o f metastases. Walker ( 19 8 0) found no such 
r e l a t i o n s h i p . A f u r t h e r study by Kuhajda e t a l . (1983) a l s o 
f a i l e d t o i d e n t i f y a c o r r e l a t i o n . These workers then 
i n v e s t i g a t e d s m a l l e r tumours (3 cm or l e s s ) and r e p o r t e d a 
t r e n d i n t h i s group f o r s t r o n g s t a i n i n g f o r CEA i n the 
p r i m a r y tumour t o be a s s o c i a t e d w i t h synchronous lymph node 
metastases, and suggested t he i n f l u e n c e o f s i z e on 
m e t a s t a t i c p o t e n t i a l c o u l d e x p l a i n t h i s d i s c r e p a n c y between 
the two s t u d i e s mentioned above. The tumours i n v e s t i g a t e d 
by Shousha and L y s s i o t i s (1978) had a mean s i z e o f 2.8 cm. 
Walker (1980) d i d not r e p o r t the mean s i z e o f the 
p o p u l a t i o n o f tumours which they i n v e s t i g a t e d , and Kuhajda 
e t a l . suggest t h a t t h i s i n v e s t i g a t i o n may have i n c l u d e d 
l a r g e r tumours. However, the t r e n d they r e p o r t i s not 
s i g n i f i c a n t (P=0.09). The p r e s e n t study found no 
r e l a t i o n s h i p between CEA d e m o n s t r a t i o n i n the p r i m a r y 
tumour and the presence o f nodal metastases a t the time o f 
mastectomy. I n t h i s work, an i n v e s t i g a t i o n o f tumours o f 
3cm diam. which s t a i n e d s t r o n g l y f o r CEA and had 
p a t h o l o g i c a l l y e s t a b l i s h e d p a t i e n t lymph node s t a t u s would 
have been meaningless due t o s m a l l numbers, ( t h e lymph node 
s t a t u s was known f o r o n l y 4 o f the s t r o n g l y s t a i n i n g 
tumours, a l t h o u g h a l l 4 tumours were 3 cm diam. or l e s s ) . 
79 
There have been t h r e e p r e v i o u s iramunohistochemical 
i n v e s t i g a t i o n s i n t o t he r e l a t i o n s h i p between CEA occurrence 
i n p r i m a r y b r e a s t carcinomas and p a t i e n t s u r v i v a l . The 
f i r s t s t u dy was conducted by Shousha e t a l . ( 1979 ) and 
i n v o l v e d 69 p a t i e n t s w i t h b r e a s t cancer. These workers 
r e p o r t e d s i g n i f i c a n t l y lower 5 and 10 year s u r v i v a l r a t e s 
f o r p a t i e n t s who possessed demonstrable CEA i n t h e i r 
tumours, and t h a t the d i f f e r e n c e was not r e l a t e d t o the 
stage o f the d i s e a s e , p o s t o p e r a t i v e t r e a t m e n t , or 
h i s t o l o g i c a l type o f tumour, and suggested t h a t t h i s CEA 
assessment may p r o v i d e more p r e c i s e p r o g n o s t i c i n f o r m a t i o n . 
The a n t i s e r u m employed i n t h i s i n v e s t i g a t i o n has been 
di s c u s s e d p r e v i o u s l y . F u r t h e r c r i t i c i s m o f t h i s work can be 
made r e g a r d i n g the method o f s t a t i s t i c a l a n a l y s i s employed. 
As d i s c u s s e d i n the s e c t i o n on the s t a t i s t i c a l methods 
employed i n the p r e s e n t study (Ch. 2 ) , the use o f 
c h i - s q u a r e d t e s t s upon the p r o p o r t i o n o f p a t i e n t s a l i v e a t 
a c e r t a i n time i n t e r v a l (as performed by Shousha et a l • , 
1979) i s i n a p p r o p r i a t e . P a t i e n t s who are l o s t t o f o l l o w - u p , 
or are known t o have d i e d from causes n o t r e l a t e d t o the 
tumour, are n e c e s s a r i l y excluded from i n v e s t i g a t i o n w i t h 
t he l o s s o f i n f o r m a t i o n and a c e r t a i n amount o f s e l e c t i o n 
b i a s . 
The second study was by Walker (1980) who employed an 
a n t i s e r u m f r e e from anti-NCA a c t i v i t y t o i n v e s t i g a t e 90 
cases. They found no c o r r e l a t i o n between the presence of 
CEA i n the p r i m a r y tumour and r e c u r r e n c e w i t h i n two years 
o f sugery, but do not mention how t h i s was e s t a b l i s h e d . 
From the t a b l e p r e s e n t e d i t would appear t h a t c h i - s q u a r e d 
t e s t s were employed as i n the p r e v i o u s s t u d y . 
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The t h i r d study i s t h a t o f R o l f Smith e t a l . ( 1 9 8 2 ) . 
Here the CEA s t a t u s o f both p r i m a r y and m e t a s t a t i c b r e a s t 
cancer was c o r r e l a t e d w i t h the c l i n i c a l course o f p a t i e n t s 
e n t e r e d i n t o a c o n t r o l l e d t r i a l o f a d j u v a n t chemotherapy 
f o r the t r e a t m e n t o f op e r a b l e b r e a s t cancer, i n o r d e r t o 
assess the value o f CEA e x p r e s s i o n as a p r o g n o s t i c 
i n d i c a t o r and as a means o f a s s e s s i n g which p a t i e n t s might 
b e n e f i t from a d j u v a n t chemotherapy. This study i s concerned 
e x c l u s i v e l y w i t h a x i l l a r y node p o s i t i v e p a t i e n t s , and 
i n v o l v e d 290 p r i m a r y carcinomas and 217 a x i l l a r y 
m etastases. The l o n g e s t f o l l o w - u p was 4 y r s 7 mths, the 
median d u r a t i o n being 2 y r s 7 mths. The anti-CEA serum 
employed was c o n s i d e r e d t o be f r e e from anti-NCA a c t i v i t y . 
These workers found no s i g n i f i c a n t c o r r e l a t i o n between CEA 
s t a t u s o f the p r i m a r y tumours and r e c u r r e n c e - f r e e s u r v i v a l 
f o r p a t i e n t s i n the u n t r e a t e d c o n t r o l group o f p a t i e n t s , or 
f o r p a t i e n t s who had r e c e i v e d a d j u v a n t chemotherapy. No 
comparisons were made f o r a c t u a l s u r v i v a l and CEA s t a t u s i n 
the p r i m a r y tumour. ( A l l comparisons made were weakly or 
n e g a t i v e l y CEA-staining a g a i n s t p o s i t i v e l y s t a i n i n g 
t u m o u r s ) . The p r e s e n t study compared s u r v i v a l i n p a t i e n t s 
w i t h p o s i t i v e lymph nodes when grouped a c c o r d i n g t o the 
presence or absence o f CEA i n the tumour. The comparison o f 
s u r v i v a l f o r p a t i e n t s w i t h n e g a t i v e or weakly s t a i n i n g 
tumours a g a i n s t t h a t f o r p a t i e n t s w i t h more s t r o n g l y 
s t a i n i n g tumours was not made f o r lymph node p o s i t i v e 
p a t i e n t s a l o n e , but f o r the p o p u l a t i o n as a whole. 
When a x i l l a r y node metastases were i n v e s t i g a t e d by 
R o l f Smith e t a l . ( 1 9 8 2 ) , however, r e c u r r e n c e - f r e e 
s u r v i v a l was s i g n i f i c a n t l y b e t t e r i n the u n t r e a t e d group 
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f o r those p a t i e n t s w i t h s t r o n g l y p o s i t i v e s t a i n i n g tumours 
than f o r those w i t h weakly s t a i n i n g or CEA n e g a t i v e 
tumours. When a c t u a l s u r v i v a l was i n v e s t i g a t e d the 
d i f f e r e n c e was not s i g n i f i c a n t . No s i g n i f i c a n t d i f f e r e n c e 
was d e t e c t e d f o r r e c u r r e n c e - f r e e s u r v i v a l when the 
chemotherapy group was s i m i l a r l y i n v e s t i g a t e d . These 
workers a l s o found t h a t p a t i e n t s i n the t r e a t m e n t group 
w i t h n e g a t i v e or weakly CEA p o s i t i v e nodes f a r e d 
s i g n i f i c a n t l y b e t t e r than s i m i l a r p a t i e n t s i n the u n t r e a t e d 
group. However, when a c t u a l s u r v i v a l was c o n s i d e r e d , the 
d i f f e r e n c e was not s i g n i f i c a n t u n t i l o n l y the weakly CEA 
p o s i t i v e nodes were c o n s i d e r e d a l o n e . No d i f f e r e n c e i n 
r e c u r r e n c e - f r e e s u r v i v a l was found when the t r e a t e d and 
c o n t r o l subgroups o f p a t i e n t s w i t h s t r o n g l y CEA p o s i t i v e 
nodes were c o n s i d e r e d . 
The a u t h o r s o f the above work s t a t e t h a t these 
c o r r e l a t i o n s were performed u s i n g l i f e t a b l e a n a l y s i s , and 
t h a t the d i f f e r e n c e s were demonstrated u s i n g the l o g r a n k 
method o f Peto e t a l . ( 1 9 7 7 ) , as used and discussed i n the 
p r e s e n t s t u d y . However, no median s u r v i v a l t i mes or 
c o n f i d e n c e i n t e r v a l s are quoted, and o f t h e s i g n i f i c a n t P . 
values quoted t h r e e g i v e these P valu e by d i r e c t 
a p p l i c a t i o n o f the c h i squared t e s t , and the remainder, 
comparing r e c u r r e n c e - f r e e s u r v i v a l f o r u n t r e a t e d and 
t r e a t e d -/+ CEA subgroup, ( g i v i n g a P valu e > 0.05 by the 
c h i squared t e s t ) i s e x a c t l y the same as the prece d i n g P 
v a l u e i n the p u b l i c a t i o n a l t h o u g h the numbers concerned are 
ve r y d i f f e r e n t and the graphs p r e s e n t e d r e s p e c t i v e l y are 
c o m p l e t e l y d i f f e r e n t a l s o . 
V a r i o u s f a c t o r s are known t o i n f l u e n c e the p r o g n o s i s 
82 
o f p a t i e n t s who are t r e a t e d f o r carcinoma o f the b r e a s t , 
(see F o r r e s t , 1971; C u t l e r 1968; Bloom and Richardson, 
1957). 
The p r e s e n t study i s i n aggreement w i t h these w e l l 
accepted c o n c l u s i o n s t h a t the s i z e and h i s t o l o g i c a l grade 
o f d i f f e r e n t i a t i o n o f the tumour, and the presence o f 
p a t h o l o g i c a l l y assessed lymph node metastases a t the time 
o f mastectomy are f a c t o r s which s i g n i f i c a n t l y a f f e c t 
s u r v i v a l r a t e s . I t c o n f i r m s t h a t p a t i e n t s who have l a r g e or 
p o o r l y d i f f e r e n t i a t e d carcinomas, or lymph node metastases 
a t the time o f o p e r a t i o n have a s i g n i f i c a n t l y reduced r a t e 
o f s u r v i v a l f o r up t o e i g h t years post s u r g e r y . 
This i n v e s t i g a t i o n found no s i g n i f i c a n t d i f f e r e n c e i n 
s u r v i v a l up t o e i g h t years post s u r g e r y when attachment o f 
the tumour was c o n s i d e r e d . A t r e n d c o u l d be seen up t o 4 
years f o r p a t i e n t s w i t h tumours a t t a c h e d t o the u n d e r l y i n g 
deep t i s s u e s h a v i n g the p o o r e s t s u r v i v a l c u r v e , then 
p a t i e n t s w i t h tumours a t t a c h e d t o the s k i n or n i p p l e , and 
p a t i e n t s h a v i n g u n a t t a c h e d tumours h a v i n g the b e s t . However 
t h i s t r e n d d i m i n i s h e d a f t e r 4 y e a r s . Cut l e r (1968) found, 
i n g e n e r a l , a s i g n i f i c a n t l y worse p r o g n o s i s (10 years post 
s u r g e r y ) f o r a t t a c h e d tumours. 
No s i g n i f i c a n t d i f f e r e n c e s c o u l d be e s t a b l i s h e d i n the 
p r e s e n t study f o r s u r v i v a l i n p a t i e n t s grouped a c c o r d i n g t o 
menopausal s t a t u s , i n p a t i e n t s grouped a c c o r d i n g t o the 
e x t e n t o f l y m p h o c y t i c i n f i l t r a t i o n , or i n p a t i e n t s grouped 
a c c o r d i n g t o the presence or absence o f an i n t r a d u c t a l 
component i n t h e i r i n v a s i v e carcinoma. 
I n o r d e r t o exclude the p o s s i b i l i t y o f these known 
p r o g n o s t i c i n d i c a t o r s from masking or b i a s i n g the 
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r e l a t i o n s h i p o f CEA presence i n the tumour and p a t i e n t 
s u r v i v a l i n t h i s s t u d y , s u r v i v a l was compared between CEA 
p o s i t i v e and n e g a t i v e cases w i t h i n d e f i n e d s u b - p o p u l a t i o n s . 
No r e p o r t s o f s i m i l a r comparisons have been made i n 
p r e v i o u s p u b l i c a t i o n s . The study o f R o l f Smith e t a l . 
(1982) excluded the p o s s i b i l i t y o f bias due t o unequal 
d i s t r i b u t i o n o f known p r o g n o s t i c f a c t o r s when s i g n i f i c a n t 
d i f f e r e n c e s i n s u r v i v a l were found by a s s e s s i n g the 
d i s t r i b u t i o n o f these f a c t o r s between the groups under 
comparison u s i n g the c h i squared t e s t . The p r e s e n t study 
d e t e c t e d no s i g n i f i c a n t d i f f e r e n c e s , i m p l y i n g t h a t 
immunohistochemical d e m o n s t r a t i o n o f CEA i n the p r i m a r y 
tumour i s o f no v a l u e i n p r o g n o s i s f o r any s e l e c t e d group 
o f p a t i e n t s i n v e s t i g a t e d . 
I t would be i n a p p r o p r i a t e t o d i s c u s s the s i g n i f i c a n c e 
o f CEA i n b r e a s t cancer w i t h o u t r e f e r e n c e t o the many 
c l i n i c a l i n v e s t i g a t i o n s which have been performed u s i n g 
measurements o f CEA i n the serum o f p a t i e n t s w i t h t h i s 
d i s e a s e . This approach has advantages and d i s a d v a n t a g e s . I t 
i s n o n - i n v a s i v e t o the p a t i e n t , and t h e r e f o r e s e r i a l 
measurements can be made f a c i l i t a t i n g the m o n i t o r i n g o f 
p a t i e n t s r e c e i v i n g t r e a t m e n t or d u r i n g " f o l l o w - u p " . 
However, i t has been e s t a b l i s h e d t h a t d e t e c t a b l e CEA 
p r o d u c t i o n i s not a d e f i n i t i v e f e a t u r e o f b r e a s t 
carcinomas, and, i n the i n s t a n c e s where a carcinoma does 
produce CEA, serum measurements may be i n f l u e n c e d by many 
v a r i a b l e s . Much work has been c a r r i e d out i n e s t a b l i s h i n g 
these v a r i a b l e s t o i n c l u d e the r a t e o f p r o d u c t i o n by tumour 
c e l l s , f a c t o r s i n f l u e n c i n g r e l e a s e o f CEA i n t o t h e 
c i r c u l a t i o n , and e x c r e t i o n by the l i v e r . 
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A study employing c u l t u r e d human carcinoma c e l l s by 
Drewinko and Yang (1976) i n d i c a t e d t h a t CEA p r o d u c t i o n i s 
l i m i t e d t o the G1 phase o f the m i t o t i c c y c l e . S t u d i e s on 
c u l t u r e d human c o l o n i c carcinoma c e l l s ( R o s e n t h a l , Tompkins 
and Rawls, 1980) showed a s t a b i l i t y o f CEA e x p r e s s i o n which 
suggested t h a t the l e v e l o f CEA expressed by a c e l l i s 
g e n e t i c a l l y controJled. Quayle ( 1982a) proposed t h a t tumour 
l y s i s may be an i m p o r t a n t f a c t o r a f f e c t i n g blood l e v e l s of 
CEA, from work on a model tumour system employing 
immune-deprived mice b e a r i n g tumour x e n o g r a f t s ( i n c l u d i n g 
the b r e a s t l i n e S32). I n l a t e r experiments u s i n g a s i m i l a r 
system, Quayle (1982b) e s t a b l i s h e d c o r r e l a t i o n o f tumour 
s i z e w i t h CEA blood l e v e l s i n h a l f the tumour l i n e s 
i n v e s t i g a t e d , and suggested the p o s s i b i l i t y o f c e n t r a l 
n e c r o s i s o f tumours t o account f o r the v a r i a b i l i t y and the 
c o n t r a d i c t o r y f i n d i n g s (no c o r r e l a t i o n w i t h tumour s i z e ) 
r e p o r t e d by Lewis and Keep C 1981 ) i n a comparable s t u d y . 
The l a t t e r a u t h o r s d i s c u s s an a r r a y of f a c t o r s which can 
p o t e n t i a l l y i n f l u e n c e c i r c u l a t i n g CEA l e v e l s , i n c l u d i n g the 
k i n e t i c s o f c e l l c y c l i n g w i t h i n i n d i v i d u a l tumours, the 
degree o f v a s c u l a r i z a t i o n and l y m p h a t i c i n v a s i o n o f 
tumours, and h o s t metabolism and d e g r a d a t i o n of c i r c u l a t i n g 
CEA. Zamcheck and M a r t i n (1981) summarized f a c t o r s 
i n f l u e n c i n g plasma CEA l e v e l s i n p a t i e n t s w i t h p a n c r e a t i c 
cancer. 
I n i t i a l c l i n i c a l s t u d i e s c o n c e r n i n g serum CEA were 
s t r u c t u r e d t o i n v e s t i g a t e t h i s substance as a marker f o r 
cancer. Laurence, Stevens, B e t t e l h e i m e t a 1. ( 1972) found 
r a i s e d plasma CEA l e v e l s i n p a t i e n t s w i t h many m a l i g n a n t 
tumours, i n c l u d i n g b r e a s t cancer. These workers a l s o 
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d e t e c t e d r a i s e d l e v e l s i n a s s o c i a t i o n w i t h i n f l a m a t i o n or 
r e g e n e r a t i o n , and concluded t h a t t h i s t e s t c o u l d not serve 
as a r o u t i n e s c r e e n i n g t e s t f o r cancer, but suggested a 
r o l e i n m o n i t o r i n g p a t i e n t s d u r i n g the post t h e r a p e u t i c 
f o l l o w - u p p e r i o d . 
Other workers (Steward, Nixon, Zamcheck and Ais e n b e r g , 
1974) proposed t h a t the p r o p o r t i o n o f r a i s e d CEA l e v e l s 
i n c r e a s e d w i t h i n c r e a s e d tumour spread, and t h a t a good 
c l i n i c a l p a t i e n t response t o t h e r a p y was m i r r o r e d by a f a l l 
i n CEA l e v e l . An i n v e s t i g a t i o n by Wang, Bu l b r o o k , Hayward, 
Hendrick and Franchimont (1975) found t h a t the p r o p o r t i o n 
o f h e a l t h y women w i t h measurable CEA was s i m i l a r t o that-
found i n women w i t h e a r l y b r e a s t cancer, and a s i m i l a r 
p r o p o r t i o n had an i n c r e a s e d l e v e l a f t e r mastectomy. These 
workers a l s o r e p o r t e d t h a t a h i g h e r p r o p o r t i o n o f women 
w i t h advanced disease had p o s i t i v e CEA t i t r e s , and proposed 
t h a t r a i s e d post mastectomy l e v e l s i m p l i e d a f a s t e r 
r e c u r r e n c e r a t e . This poposal was made aga i n by Myers, 
S u t h e r l a n d , Meakin, K e l l e n , M a l k i n and M a l k i n ( 1 9 7 8 ) . The 
stu d y o f Haagensen, K i s t e r , Vandevoorde e t a l . (1978) 
r e p o r t e d e l e v a t e d CEA l e v e l s i n a post mastectomy 
p o p u l a t i o n t o be a s s o c i a t e d w i t h development o f metastases 
i n 1/3 s u b j e c t s . Tormey and Waalkes (1978) r e p o r t e d t h a t 
the percentage o f p a t i e n t s w i t h e l e v a t e d CEA l e v e l s 
i n c r e a s e d w i t h each c l i n i c a l stage o f b r e a s t cancer. 
Rimsten, Adami, Wahren and Nordin ( 1 9 7 8 ) , however, r e p o r t e d 
a s i m i l a r f r e q u e n c y o f r a i s e d CEA i n p a t i e n t w i t h p r i m a r y 
b r e a s t cancer and i n h e a l t h y age-matched c o n t r o l s . 
Subsequently, the i m p l i c a t i o n s f o r CEA i n the serum o f 
p a t i e n t s w i t h b r e a s t cancer evolved from t h a t o f a marker 
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f o r the d i s e a s e , t o t h a t o f a m o n i t o r . McCarty, Cox, S i l v a 
e t a l . (1980) i n v e s t i g a t e d CEA l e v e l s i n the c l i n i c a l 
response t o hormone t h e r a p y , and found t h a t the maximum 
f u n c t i o n a l decrease o f e l e v a t e d l e v e l s c o r r e l a t e d l i n e a r l y 
w i t h the d u r a t i o n o f response i n p a t i e n t s who r e c e i v e d 
hormone t h e r a p y . Other i n v e s t i g a t i o n s (De Jong-Bakker, 
H a r t , P e r s i j n and C l e t o n , 19 81) i n d i c a t e d t h a t a 
p r e - t r e a t m e n t CEA l e v e l was found t o have no r e l a t i o n t o 
p r o g n o s i s , but a r i s e d u r i n g f o l l o w - u p was u s u a l l y 
a s s o c i a t e d w i t h p r o g r e s s i v e d i s e a s e . C h a t a l , Chupin, 
R i c o l l e a u e t a 1. (1981 ) suggested the use o f s e r i a l assays 
t o d e t e c t r e l a p s e s i n "high r i s k " p a t i e n t s . S i m i l a r l y , 
Doyle, N i c h o l s o n , Groome and Blarney (1981) concluded t h a t 
CEA i s o f no p r o g n o s t i c value i n p r i m a r y stage b r e a s t 
cancer, but c o u l d be o f value i n m o n i t o r i n g t r e a t m e n t i n 
p a t i e n t s w i t h advanced d i s e a s e , s a v i n g many p a t i e n t s from 
s u f f e r i n g s i d e e f f e c t s o f s e v e r a l unnecessary c y c l e s o f 
chemotherapy. T h i s argument was a l s o put f o r e w a r d by o t h e r 
workers ( F a l k s o n , F o l k s o n , P o r t u g a l , van der Watt and 
Schoeman, 1982). Others (Staab, Ahlemann, Anderer, Hiesche 
and Rodatz, 1981) found t h a t b e f o r e t r e a t m e n t t h e r e was a 
h i g h e r i n c i d e n c e o f r a i s e d serum CEA w i t h d i s t a n t 
metastases than i n p a t i e n t s w i t h l o c a l d i s e a s e . Bezwoda, 
Derrnan, B o t h w e l l , MacPhil, L e v i n and De Moor (1981) a l s o 
found l e v e l s o f serum CEA t o be h i g h e r i n p a t i e n t s w i t h 
metastases. Lee ( 1 983 ) observed a pronounced e l e v a t i o n of 
CEA most f r e q u e n t l y i n p a t i e n t s w i t h h e p a t i c and osseous 
metastases, s u p p o r t i n g the s i m i l a r p r e v i o u s f i n d i n g s o f 
Tormey and Waalkes ( 1 9 7 8 ) . Other s u g g e s t i o n s i n c l u d e a r o l e 
f o r the s e r i a l measurement o f c e r e b r o - s p i n a l f l u i d CEA i n 
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t h e c l i n i c a l management o f m e n i n g e a l c a r c i n o m a t o s i s i n 
p a t i e n t s w i t h b r e a s t c a n c e r . 
Serum CEA has been e x t e n s i v e l y i n v e s t i g a t e d i n a 
s i m i l a r manner i n p a t i e n t s w i t h a v a r i e t y o f m a l i g n a n t 
d i s e a s e s , i n c l u d i n g t h o s e o f t h e l u n g ( W a a l k e s , A b e l o f f , 
Woo, E t t i n g e r , Ruddon and A l d e n d e r f e r , 1980; G o s l i n , S k a r i n 
and Zamcheck, 1981; Woo, W a a l k e s , A b e l o f f , E t t i n g e r , M c N i t t 
and G e h r k e , 1981; L o k i c h , 1982), b r o n c h i a l c a r c i n o m a s 
(Paone, K a r d a n a , R o g e r s , Dhasmanda and J e y a s i n g h a m , 1 9 S 0 ) , 
c a r c i n o m a o f t h e c e r v i x ( D o n a l d s o n , van N a g e l l , P u r s e l l , 
Gay, Meeker, K a s h m i r i and van de V o o r d e , 1980; K j o r s t a d and 
O r j a s a e s t e r , 1982; Te V e l d e , P e r s i j n , B a l l i e u x and F a b e r , 
1982), c a r c i n o m a o f t h e p a n c r e a s (Zamcheck and M a r t i n , 
1981), hepatomas ( M e l i a , J o h n s o n , C a r t e r , Munroe N e v i l l e 
and W i l l i a m s , 1981), t u m o u r s o f t h e t h y r o i d ( R o u g i e r , 
C a l m e t t e s , L a p l a n c h e , T r a v a g l i , L e f e v r e , P a r m e n t i e r , 
M i l h a u d and T u b i a n a , 19 8 3 ) , and e s p e c i a l l y c o l o r e c t a l 
c a r c i n o m a s ( G o s l i n , S t e e l e , M a c i n t y r e , Mayer, S u g a r b a k e r , 
C l e g h o r n , W i l s o n and Zamcheck, 19 8 0; Rognum, E l g j o , 
B r a n d t z a e g , O r j a s a e t e r and B e r g a n , 1982; F i n l a y and 
M c A r d l e , 1983; Rognum and B r a n d t z a e g , 1983; G o l d e n b e r g , 
Kim, B e n n e t t . N e l s o n and D e l a n d , 1983), 
A N a t i o n a l I n s t i t u t e s o f H e a l t h Consensus D e v e l o p m e n t 
C o n f e r e n c e was h e l d i n 1980 t o a d d r e s s i s s u e s c o n c e r n i n g 
t h e r o l e o f CEA i n t h e management o f c a n c e r . The 
c o n c l u s i o n s o f t h i s c o n f e r e n c e were t h a t CEA s h o u l d n o t be 
used i n c a n c e r s c r e e n i n g , n o r i n d e p e n d e n t l y t o e s t a b l i s h a 
d i a g n o s i s o f c a n c e r , b u t t h a t CEA may have v a l u e i n 
a s s e s s i n g t h e e x t e n t o f t h e d i s e a s e i n c o l o r e c t a l and 
b r o n c h i a l c a r c i n o m a s , and i n m o n i t o r i n g t h e t r e a t m e n t o f 
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c o l o r e c t a l cancer, w h i l s t t h e arguments f o r a s s e s s i n g and 
m o n i t o r i n g CEA i n o t h e r carcinomas were i n t e r p r e t e d as much 
l e s s c o n v i n c i n g , (see summary NIH Consensus Statement, 
1981). At p r e s e n t i t would appear t h a t c l i n i c a l assessment 
by serum CEA l a c k s s e n s i t i v i t y and s p e c i f i c i t y . 
The r e s u l t s o f the p r e s e n t study suggest t h a t 
assessment o f h i s t o l o g i c a l l y d e t e c t a b l e CEA has s i m i l a r 
l i m i t a t i o n s , and i s o f no v a l u e as an i n d i c a t o r o f p a t i e n t 
p r o g n o s i s . 
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ITEM SHEET NO. 
DATE OF B I R T H 
AGE 
DATE ADMITTED 
1 2 3 
11 12 
13 1 4 
it CD 
5 6 7 tZEXI 10 
1 5 16 1 7 18 
MENOPAUSAL STATUS 
Premenopausal ( l a s t 
Perimenopausal ( l a s t 
Postmenopausal ( l a s t 
Uncertain ( i n c . 
Not a v a i l a b l e 
E X A K I N A T I C N 
Weight i n kgs. 
Weight i n s t . l b s . 
S I T E O F TUMOUR 
R I G H T 
MIGHT 
YES 




to 5 y r s ago) 




SIZE OF TUMOUR 
More than 5 cm. max. diarn. 
L e s s than 5 cm. max. diam. 
ATTACHMENT OF TUMOUR 
Sk i n or nipple 
Deep 
LYMPH NODES 
I p s i l : \ t e r a l a x i l l a r y nodes:-
none palpable 
palpable - c l i n i c a l l y not involved 
c l i n i c a l l y involved 




leave blank i f not done 
S k e l e t a l survey:-
s u s p i c i o u s 
not s u s p i c i o u s 
Bono scan:-
s u s p i c i o u s 
not s u s p i c i o u s 




20 21 22 rza 
2 3 2k 2 5 26 
I ft 
\6 
i t _ i 
1 ,AS 
2 I 
A 27 J 35 
B 28 K 36 
C 29 L 37 
D 30 M 38 
E 31 N 39 
F 32 P 4 0 
G 33 R 41 
H 34 S 
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IDENTIFICATION NO. 
ITEM SHEET NO. 
OPERATION DATE 
I I I I 
k 
5 6 7 8 9 10 
I I I L L J _ I 
METHuD BIOPSY:-
E x c i s i o n biopsy 1 
I n c i s i o n biopsy 2 








TYPE OF OPERATION:. 
L o c a l e x c i s i o n 
T o t a l simple mastectomy 
Simple mastectomy with totr.l 
a x i l l a r y clearance ( i n c . 
patey mastectomy) 
C l a s s i c a l r a d i c a l 
3 
NODE BIOPSY (only complete i f t o t a l 
simple mastectomy performed):-





One or two 2 














I D E N T I F I C A T I O N NO. | ) 
I T E M S H E E T NO. 
P A T I E N T K L I V E : 
No recurrence detectable 
Recurrent d i s e a s e l o c a l 
Recurrent d i s e a s e d i s t a n t 
PATIENT DEJLD: 
Date of death 
»utopsy c a r r i e d out 
autopsy not c a r r i e d out 
6 7 8 9 1 0 11 
I I I L i _ L 
1 2 • 
C.USE OF DEnTH: 
Breasc cancer 1 
Other causes - breast cancer 
present 2 
Other causes - breast cancer 
not present J 
U n c ertain k 




ITEM SHiOiJl' No. 
if 
HISTOLOGY BIOPSY NO. I ! 
l-UCXSCoFIC .±V£iJZl&C£ OF BKJW.S'I' TUMOUR:_ 
11 12 
Maximum dimension i n ens. 
Tumour edge: 
woll defined 1 
poorly defined 2 
not known 3 
I n t r a d u c t carcinoma Yes 1 
a 
• 
No. of ^ x i l l f r y Lymph Nodes found: 
none 1 
one or two 2 
mor<- than two 3 
HISTOLOGIC/J, ^PJSiiJOiHCB O F XU^UIiS: 






Lobular i n s i t u Yes 1 I 
Paget's di s e a s e Yes 1 { j 
Grade of tumour: 
w e l l d i f f e r e n t i a t e d 1 
moderately d i f f o r o n t i a t e d 2 
poorly d i f f e r e n t i a t e d 3 
Lymnhocyte i n f i l t r a t i o n i n and around tumour: 
0* 1 20 
2 ! 
4-4- ^ U 
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1 2 3 
IDENTIFICATION NO. | I I 
k 
I T E M S H E E T NO. I 5 [ 
IMMUNOLOCALISATION - RETRuSI-ECTIVE P A R A F F I N 
Carcinoembryonic antigen 
Immunoneroxidase 0 1=Yes 
+ 0 
1+ 1 
2+ 2 
3+ 3 
